1
|
Crous PW, Boers J, Holdom D, Osieck ER, Steinrucken TV, Tan YP, Vitelli JS, Shivas RG, Barrett M, Boxshall AG, Broadbridge J, Larsson E, Lebel T, Pinruan U, Sommai S, Alvarado P, Bonito G, Decock CA, De la Peña-Lastra S, Delgado G, Houbraken J, Maciá-Vicente JG, Raja HA, Rigueiro-Rodríguez A, Rodríguez A, Wingfield MJ, Adams SJ, Akulov A, Al-Hidmi T, Antonín V, Arauzo S, Arenas F, Armada F, Aylward J, Bellanger JM, Berraf-Tebbal A, Bidaud A, Boccardo F, Cabero J, Calledda F, Corriol G, Crane JL, Dearnaley JDW, Dima B, Dovana F, Eichmeier A, Esteve-Raventós F, Fine M, Ganzert L, García D, Torres-Garcia D, Gené J, Gutiérrez A, Iglesias P, Istel Ł, Jangsantear P, Jansen GM, Jeppson M, Karun NC, Karich A, Khamsuntorn P, Kokkonen K, Kolařík M, Kubátová A, Labuda R, Lagashetti AC, Lifshitz N, Linde C, Loizides M, Luangsa-Ard JJ, Lueangjaroenkit P, Mahadevakumar S, Mahamedi AE, Malloch DW, Marincowitz S, Mateos A, Moreau PA, Miller AN, Molia A, Morte A, Navarro-Ródenas A, Nebesářová J, Nigrone E, Nuthan BR, Oberlies NH, Pepori AL, Rämä T, Rapley D, Reschke K, Robicheau BM, Roets F, Roux J, Saavedra M, Sakolrak B, Santini A, Ševčíková H, Singh PN, Singh SK, Somrithipol S, Spetik M, Sridhar KR, Starink-Willemse M, Taylor VA, van Iperen AL, Vauras J, Walker AK, Wingfield BD, Yarden O, Cooke AW, Manners AG, Pegg KG, Groenewald JZ. Fungal Planet description sheets: 1383-1435. Persoonia 2022; 48:261-371. [PMID: 38234686 PMCID: PMC10792288 DOI: 10.3767/persoonia.2023.48.08] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Figures] [Subscribe] [Scholar Register] [Received: 04/10/2022] [Accepted: 05/20/2022] [Indexed: 01/19/2024]
Abstract
Novel species of fungi described in this study include those from various countries as follows: Australia, Agaricus albofoetidus, Agaricus aureoelephanti and Agaricus parviumbrus on soil, Fusarium ramsdenii from stem cankers of Araucaria cunninghamii, Keissleriella sporoboli from stem of Sporobolus natalensis, Leptosphaerulina queenslandica and Pestalotiopsis chiaroscuro from leaves of Sporobolus natalensis, Serendipita petricolae as endophyte from roots of Eriochilus petricola, Stagonospora tauntonensis from stem of Sporobolus natalensis, Teratosphaeria carnegiei from leaves of Eucalyptus grandis × E. camaldulensis and Wongia ficherai from roots of Eragrostis curvula. Canada, Lulworthia fundyensis from intertidal wood and Newbrunswickomyces abietophilus (incl. Newbrunswickomyces gen. nov.) on buds of Abies balsamea. Czech Republic, Geosmithia funiculosa from a bark beetle gallery on Ulmus minor and Neoherpotrichiella juglandicola (incl. Neoherpotrichiella gen. nov.) from wood of Juglans regia. France, Aspergillus rouenensis and Neoacrodontium gallica (incl. Neoacrodontium gen. nov.) from bore dust of Xestobium rufovillosum feeding on Quercus wood, Endoradiciella communis (incl. Endoradiciella gen. nov.) endophytic in roots of Microthlaspi perfoliatum and Entoloma simulans on soil. India, Amanita konajensis on soil and Keithomyces indicus from soil. Israel, Microascus rothbergiorum from Stylophora pistillata. Italy, Calonarius ligusticus on soil. Netherlands, Appendopyricularia juncicola (incl. Appendopyricularia gen. nov.), Eriospora juncicola and Tetraploa juncicola on dead culms of Juncus effusus, Gonatophragmium physciae on Physcia caesia and Paracosmospora physciae (incl. Paracosmospora gen. nov.) on Physcia tenella, Myrmecridium phragmitigenum on dead culm of Phragmites australis, Neochalara lolae on stems of Pteridium aquilinum, Niesslia nieuwwulvenica on dead culm of undetermined Poaceae, Nothodevriesia narthecii (incl. Nothodevriesia gen. nov.) on dead leaves of Narthecium ossifragum and Parastenospora pini (incl. Parastenospora gen. nov.) on dead twigs of Pinus sylvestris. Norway, Verticillium bjoernoeyanum from sand grains attached to a piece of driftwood on a sandy beach. Portugal, Collybiopsis cimrmanii on the base of living Quercus ilex and amongst dead leaves of Laurus and herbs. South Africa, Paraproliferophorum hyphaenes (incl. Paraproliferophorum gen. nov.) on living leaves of Hyphaene sp. and Saccothecium widdringtoniae on twigs of Widdringtonia wallichii. Spain, Cortinarius dryosalor on soil, Cyphellophora endoradicis endophytic in roots of Microthlaspi perfoliatum, Geoglossum lauri-silvae on soil, Leptographium gemmatum from fluvial sediments, Physalacria auricularioides from a dead twig of Castanea sativa, Terfezia bertae and Tuber davidlopezii in soil. Sweden, Alpova larskersii, Inocybe alpestris and Inocybe boreogodeyi on soil. Thailand, Russula banwatchanensis, Russula purpureoviridis and Russula lilacina on soil. Ukraine, Nectriella adonidis on overwintered stems of Adonis vernalis. USA, Microcyclus jacquiniae from living leaves of Jacquinia keyensis and Penicillium neoherquei from a minute mushroom sporocarp. Morphological and culture characteristics are supported by DNA barcodes. Citation: Crous PW, Boers J, Holdom D, et al. 2022. Fungal Planet description sheets: 1383-1435. Persoonia 48: 261-371. https://doi.org/10.3767/persoonia.2022.48.08.
Collapse
Affiliation(s)
- P W Crous
- Westerdijk Fungal Biodiversity Institute, P.O. Box 85167, 3508 AD Utrecht, The Netherlands
- Department of Biochemistry, Genetics and Microbiology, Forestry and Agricultural Biotechnology Institute (FABI), University of Pretoria, Pretoria, South Africa
| | - J Boers
- Moleneinde 15, 7991 AK, Dwingeloo, The Netherlands
| | - D Holdom
- Biosecurity Queensland, Dutton Park 4102, Queensland, Australia
| | - E R Osieck
- Jkvr. C.M. van Asch van Wijcklaan 19, 3972 ST Driebergen-Rijsenburg, The Netherlands
| | | | - Y P Tan
- Plant Pathology Herbarium, Department of Agriculture and Fisheries, Dutton Park 4102, Queensland, Australia
| | - J S Vitelli
- Biosecurity Queensland, Dutton Park 4102, Queensland, Australia
| | - R G Shivas
- Centre for Crop Health, University of Southern Queensland, Toowoomba 4350, Queensland, Australia
| | - M Barrett
- James Cook University, Cairns, Queensland, Australia
| | | | | | - E Larsson
- Biological and Environmental Sciences, Gothenburg Global Biodiversity Centre, University of Gothenburg, Box 461, SE-40530 Göteborg, Sweden
| | - T Lebel
- State Herbarium of South Australia, South Australia, Australia
| | - U Pinruan
- Plant Microbe Interaction Research Team (APMT), BIOTEC, National Science and Technology Development Agency, Pathum Thani, Thailand, 113 Thailand Science Park, Phahonyothin Rd., Khlong Nueng, Khlong Luang, Pathum Thani Thailand
| | - S Sommai
- Plant Microbe Interaction Research Team (APMT), BIOTEC, National Science and Technology Development Agency, Pathum Thani, Thailand, 113 Thailand Science Park, Phahonyothin Rd., Khlong Nueng, Khlong Luang, Pathum Thani Thailand
| | - P Alvarado
- ALVALAB, Dr. Fernando Bongera st., Severo Ochoa bldg. S1.04, 33006 Oviedo, Spain
| | - G Bonito
- Michigan State University, East Lansing, Michigan, USA
| | - C A Decock
- Mycothèque de l'Université catholique de Louvain (MUCL, BCCMTM), Earth and Life Institute - ELIM - Mycology, Université catholique de Louvain, Croix du Sud 2 bte L7.05.06, B-1348 Louvain-la-Neuve, Belgium
| | | | - G Delgado
- Eurofins EMLab P&K Houston, 10900 Brittmoore Park Dr. Suite G, Houston, Texas 77041, USA
| | - J Houbraken
- Westerdijk Fungal Biodiversity Institute, P.O. Box 85167, 3508 AD Utrecht, The Netherlands
| | - J G Maciá-Vicente
- Plant Ecology and Nature Conservation, Wageningen University & Research, P.O. Box 47, 6700 AA Wageningen, The Netherlands
- Department of Microbial Ecology, Netherlands Institute for Ecology (NIOO-KNAW), P.O. Box 50, 6700 Wageningen, The Netherlands
| | - H A Raja
- Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina 27402, USA
| | | | - A Rodríguez
- Departamento de Biología Vegetal (Botánica), Facultad de Biología, Universidad de Murcia, 30100 Murcia, Spain
| | - M J Wingfield
- Department of Biochemistry, Genetics and Microbiology, Forestry and Agricultural Biotechnology Institute (FABI), University of Pretoria, Pretoria, South Africa
| | - S J Adams
- Department of Biology, Acadia University, 33 Westwood Avenue, Wolfville, Nova Scotia, B4P 2R6 Canada
| | - A Akulov
- Department of Mycology and Plant Resistance, V. N. Karazin Kharkiv National University, Maidan Svobody 4, 61022 Kharkiv, Ukraine
| | - T Al-Hidmi
- Centre for Crop Health, University of Southern Queensland, Toowoomba 4350, Queensland, Australia
| | - V Antonín
- Department of Botany, Moravian Museum, Zelný trh 6, 65937 Brno, Czech Republic
| | - S Arauzo
- Asociación Micológica Errotari de Durango, Spain
| | - F Arenas
- Departamento de Biología Vegetal (Botánica), Facultad de Biología, Universidad de Murcia, 30100 Murcia, Spain
| | - F Armada
- 203, montée Saint-Mamert-le-Haut, F-38138 Les Côtes-d'Arey, France
| | - J Aylward
- Department of Biochemistry, Genetics and Microbiology, Forestry and Agricultural Biotechnology Institute (FABI), University of Pretoria, Pretoria, South Africa
| | - J-M Bellanger
- CEFE, CNRS, Université de Montpellier, EPHE, IRD, INSERM, 1919 route de Mende, F-34293 Montpellier Cédex 5, France
| | - A Berraf-Tebbal
- MENDELEUM - Institute of Genetics, Mendel University in Brno, Valticka 334, Lednice, 69144, Czech Republic
| | - A Bidaud
- 2436, route de Brailles, F-38510 Vézeronce-Curtin, France
| | - F Boccardo
- Via Filippo Bettini 14/11, 16162, Genova, Italy
| | - J Cabero
- C/ El Sol 6. 49800 Toro, Zamora, Spain
| | - F Calledda
- Via 25 aprile, 76, 20051, Cassina De Pecchi (MI), Italy
| | - G Corriol
- National Botanical Conservatory of the Pyrenees and Midi-Pyrenees. Vallon de Salut, BP 70315, 65203 Bagnères-de-Bigorre, France
| | - J L Crane
- University of Illinois Urbana-Champaign, Illinois Natural History Survey, 1816 South Oak Street, Champaign, Illinois, 61820, USA
| | - J D W Dearnaley
- Centre for Crop Health, University of Southern Queensland, Toowoomba 4350, Queensland, Australia
| | - B Dima
- Department of Plant Anatomy, Institute of Biology, Eötvös Loránd University, Pázmány Péter sétány 1/C, H-1117, Budapest, Hungary
| | - F Dovana
- Via Quargnento, 17, 15029, Solero (AL), Italy
| | - A Eichmeier
- MENDELEUM - Institute of Genetics, Mendel University in Brno, Valticka 334, Lednice, 69144, Czech Republic
| | - F Esteve-Raventós
- Departemento de Ciencias de la Vida, Botánica, Universidad de Alcalá. Alcalá de Henares, E28805 Madrid, Spain
| | - M Fine
- Department of Ecology, Evolution & Behavior, The Alexander Silberman Institute of Life Science, The Hebrew University of Jerusalem, Jerusalem, Israel & Interuniversity Institute of Marine Sciences, Eilat, Israel
| | - L Ganzert
- Marbio, Norwegian College of Fishery Science, UiT The Arctic University of Norway, Tromsø, Norway
| | - D García
- Mycology Unit, Medical School and IISPV, Universitat Rovira i Virgili, Sant Llorenç 21, 43201 Reus, Spain
| | - D Torres-Garcia
- Mycology Unit, Medical School and IISPV, Universitat Rovira i Virgili, Sant Llorenç 21, 43201 Reus, Spain
| | - J Gené
- Mycology Unit, Medical School and IISPV, Universitat Rovira i Virgili, Sant Llorenç 21, 43201 Reus, Spain
| | - A Gutiérrez
- Departamento de Biología Vegetal (Botánica), Facultad de Biología, Universidad de Murcia, 30100 Murcia, Spain
| | - P Iglesias
- Asociación Micológica Errotari de Durango, Spain
| | - Ł Istel
- Westerdijk Fungal Biodiversity Institute, P.O. Box 85167, 3508 AD Utrecht, The Netherlands
| | - P Jangsantear
- Forest and Plant Conservation Research Office, Department of National Parks, Wildlife and Plant Conservation, Chatuchak District, Bangkok, Thailand
| | | | - M Jeppson
- Biological and Environmental Sciences, Gothenburg Global Biodiversity Centre, University of Gothenburg, Box 461, SE-40530 Göteborg, Sweden
| | - N C Karun
- Department of Biosciences, Mangalore University, Mangalagangotri, Mangalore 574199, Karnataka, India
| | - A Karich
- TU Dresden, International Institute Zittau, Markt 23, 02763 Zittau, Germany
| | - P Khamsuntorn
- Plant Microbe Interaction Research Team (APMT), BIOTEC, National Science and Technology Development Agency, Pathum Thani, Thailand, 113 Thailand Science Park, Phahonyothin Rd., Khlong Nueng, Khlong Luang, Pathum Thani Thailand
| | - K Kokkonen
- Biodiversity Unit, Herbarium, University of Turku, FI-20014 Turku, Finland
| | - M Kolařík
- Institute of Microbiology of the CAS, Vídeňská 1083, 14220, Prague, Czech Republic
| | - A Kubátová
- Department of Botany, Culture Collection of Fungi (CCF), Faculty of Science, Charles University, Benátská 2, 128 00 Prague 2, Czech Republic
| | - R Labuda
- Department for Farm Animals and Veterinary Public Health, Institute of Food Safety, Food Technology and Veterinary Public Health; Unit of Food Microbiology, University of Veterinary Medicine Vienna, Veterinaerplatz 1, 1210 Vienna, Austria, and Research Platform Bioactive Microbial Metabolites (BiMM), Konrad Lorenz Strasse 24, 3430 Tulln a.d. Donau, Austria
| | - A C Lagashetti
- National Fungal Culture Collection of India (NFCCI), Biodiversity and Palaeobiology Group, MACS-Agharkar Research Institute, G.G. Agarkar Road, Pune 411004, India
| | - N Lifshitz
- Department of Plant Pathology and Microbiology, The Robert H. Smith Faculty of Agriculture, The Hebrew University of Jerusalem, Rehovot, Israel & Interuniversity Institute of Marine Sciences, Eilat, Israel
| | - C Linde
- Ecology and Evolution, Research School of Biology, College of Science, The Australian National University, Canberra, ACT, 2601, Australia
| | | | - J J Luangsa-Ard
- Plant Microbe Interaction Research Team (APMT), BIOTEC, National Science and Technology Development Agency, Pathum Thani, Thailand, 113 Thailand Science Park, Phahonyothin Rd., Khlong Nueng, Khlong Luang, Pathum Thani Thailand
| | - P Lueangjaroenkit
- Department of Microbiology, Faculty of Science, Kasetsart University, Bangkok, Thailand
| | - S Mahadevakumar
- Department of Studies in Botany, University of Mysore, Manasagangotri, Mysore 570006, Karnataka, India; Present Address: Forest Pathology Department, Division of Forest Protection, KSCSTE - Kerala Forest Research Institute, Peechi 680653, Thrissur, Kerala, India
| | - A E Mahamedi
- Laboratoire de Biologie des Systèmes Microbiens (LBSM), Ecole Normale Supérieure de Kouba, B.P 92 16308 Vieux-Kouba, Alger, Algeria
| | - D W Malloch
- New Brunswick Museum, 277 Douglas Ave., Saint John, New Brunswick, Canada E2K 1E5
| | - S Marincowitz
- Department of Biochemistry, Genetics and Microbiology, Forestry and Agricultural Biotechnology Institute (FABI), University of Pretoria, Pretoria, South Africa
| | - A Mateos
- Sociedad Micológica Extremeña, C/ Sagitario 14, 10001 Cáceres, Spain
| | - P-A Moreau
- ULR 4515 - LGCgE, Faculté de pharmacie, Univ. Lille, F-59000 Lille, France
| | - A N Miller
- University of Illinois Urbana-Champaign, Illinois Natural History Survey, 1816 South Oak Street, Champaign, Illinois, 61820, USA
| | - A Molia
- Alette Iversens gate 5, N-3970 Langesund, Norway
| | - A Morte
- Departamento de Biología Vegetal (Botánica), Facultad de Biología, Universidad de Murcia, 30100 Murcia, Spain
| | - A Navarro-Ródenas
- Departamento de Biología Vegetal (Botánica), Facultad de Biología, Universidad de Murcia, 30100 Murcia, Spain
| | - J Nebesářová
- Laboratory of Electron Microscopy, Faculty of Science, Charles University, Viničná 7, 128 00 Prague 2, Czech Republic
| | - E Nigrone
- Institute of Sustainable Plant Protection, C.N.R. Via Madonna del Piano, 10 50019 Sesto fiorentino, Italy
| | - B R Nuthan
- Department of Studies in Microbiology, University of Mysore, Manasagangotri, Mysore 570006, Karnataka, India
| | - N H Oberlies
- Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina 27402, USA
| | - A L Pepori
- Institute of Sustainable Plant Protection, C.N.R. Via Madonna del Piano, 10 50019 Sesto fiorentino, Italy
| | - T Rämä
- Marbio, Norwegian College of Fishery Science, UiT The Arctic University of Norway, Tromsø, Norway
| | - D Rapley
- Biosecurity Queensland, Dutton Park 4102, Queensland, Australia
| | - K Reschke
- Mycology Research Group, Faculty of Biological Sciences, Goethe University Frankfurt am Main, Max-von-Laue Straße 13, 60439 Frankfurt am Main, Germany
| | - B M Robicheau
- Department of Biology, Acadia University, 33 Westwood Avenue, Wolfville, Nova Scotia, B4P 2R6 Canada
- Department of Biology, Dalhousie University, 1355 Oxford Street, Halifax, Nova Scotia, B3H 4R2 Canada
| | - F Roets
- Department of Conservation Ecology and Entomology, Stellenbosch University, Stellenbosch 7600, South Africa
| | - J Roux
- Department of Plant and Soil Sciences, Forestry and Agricultural Biotechnology Institute (FABI), Faculty of Natural and Agricultural Sciences, University of Pretoria, Private Bag X20, Hatfield 0028, Pretoria, South Africa
| | - M Saavedra
- Asociación "Andoa" de Cambre y componente del "Colectivo Micolóxico Coruñés" de A Coruña, Spain
| | - B Sakolrak
- Forest and Plant Conservation Research Office, Department of National Parks, Wildlife and Plant Conservation, Chatuchak District, Bangkok, Thailand
| | - A Santini
- Institute of Sustainable Plant Protection, C.N.R. Via Madonna del Piano, 10 50019 Sesto fiorentino, Italy
| | - H Ševčíková
- Department of Botany, Moravian Museum, Zelný trh 6, 65937 Brno, Czech Republic
| | - P N Singh
- National Fungal Culture Collection of India (NFCCI), Biodiversity and Palaeobiology Group, MACS-Agharkar Research Institute, G.G. Agarkar Road, Pune 411004, India
| | - S K Singh
- National Fungal Culture Collection of India (NFCCI), Biodiversity and Palaeobiology Group, MACS-Agharkar Research Institute, G.G. Agarkar Road, Pune 411004, India
| | - S Somrithipol
- Plant Microbe Interaction Research Team (APMT), BIOTEC, National Science and Technology Development Agency, Pathum Thani, Thailand, 113 Thailand Science Park, Phahonyothin Rd., Khlong Nueng, Khlong Luang, Pathum Thani Thailand
| | - M Spetik
- MENDELEUM - Institute of Genetics, Mendel University in Brno, Valticka 334, Lednice, 69144, Czech Republic
| | - K R Sridhar
- Department of Biosciences, Mangalore University, Mangalagangotri, Mangalore 574199, Karnataka, India
| | - M Starink-Willemse
- Westerdijk Fungal Biodiversity Institute, P.O. Box 85167, 3508 AD Utrecht, The Netherlands
| | - V A Taylor
- Department of Biology, Acadia University, 33 Westwood Avenue, Wolfville, Nova Scotia, B4P 2R6 Canada
- Faculty of Medicine, Dalhousie University, 5849 University Ave, Halifax, Nova Scotia B3H 4R2 Canada
| | - A L van Iperen
- Westerdijk Fungal Biodiversity Institute, P.O. Box 85167, 3508 AD Utrecht, The Netherlands
| | - J Vauras
- Biological Collections of Åbo Akademi University, Herbarium, University of Turku, FI-20014 Turku, Finland
| | - A K Walker
- Department of Biology, Acadia University, 33 Westwood Avenue, Wolfville, Nova Scotia, B4P 2R6 Canada
| | - B D Wingfield
- Department of Biochemistry, Genetics and Microbiology, Forestry and Agricultural Biotechnology Institute (FABI), University of Pretoria, Pretoria, South Africa
| | - O Yarden
- Department of Plant Pathology and Microbiology, The Robert H. Smith Faculty of Agriculture, The Hebrew University of Jerusalem, Rehovot, Israel & Interuniversity Institute of Marine Sciences, Eilat, Israel
| | - A W Cooke
- Agri-Science Queensland, Department of Agriculture and Fisheries, Dutton Park 4102, Queensland, Australia
| | - A G Manners
- Agri-Science Queensland, Department of Agriculture and Fisheries, Dutton Park 4102, Queensland, Australia
| | - K G Pegg
- Agri-Science Queensland, Department of Agriculture and Fisheries, Dutton Park 4102, Queensland, Australia
| | - J Z Groenewald
- Westerdijk Fungal Biodiversity Institute, P.O. Box 85167, 3508 AD Utrecht, The Netherlands
| |
Collapse
|
2
|
Meiser B, Kaur R, Morrow A, Peate M, Wong WKT, McPike E, Cops E, Nichols C, Austin R, Fine M, Thrupp L, Ward R, Macrae F, Hiller JE, Trainer AH, Mitchell G. Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice. Hered Cancer Clin Pract 2021; 19:24. [PMID: 33836815 PMCID: PMC8035714 DOI: 10.1186/s13053-021-00180-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2021] [Accepted: 03/24/2021] [Indexed: 11/25/2022] Open
Abstract
Background This nationwide study assessed the impact of nationally agreed cancer genetics guidelines on use of BRCA1/2 germline testing, risk management advice given by health professionals to women with pathogenic BRCA1/2 variants and uptake of such advice by patients. Methods Clinic files of 883 women who had initial proband screens for BRCA1/2 pathogenic variants at 12 familial cancer clinics between July 2008–July 2009 (i.e. before guideline release), July 2010–July 2011 and July 2012–July 2013 (both after guideline release) were audited to determine reason given for genetic testing. Separately, the clinic files of 599 female carriers without a personal history of breast/ovarian cancer who underwent BRCA1/2 predictive genetic testing and received their results pre- and post-guideline were audited to ascertain the risk management advice given by health professionals. Carriers included in this audit were invited to participate in a telephone interview to assess uptake of advice, and 329 agreed to participate. Results There were no significant changes in the percentages of tested patients meeting at least one published indication for genetic testing - 79, 77 and 78% of files met criteria before guideline, and two-, and four-years post-guideline, respectively (χ = 0.25, p = 0.88). Rates of documentation of post-test risk management advice as per guidelines increased significantly from pre- to post-guideline for 6/9 risk management strategies. The strategies with the highest compliance amongst carriers or awareness post-release of guidelines were annual magnetic resonance imaging plus mammography in women 30–50 years (97%) and annual mammography in women > 50 years (92%). Of women aged over 40 years, 41% had a risk-reducing bilateral mastectomy. Amongst women aged > 40 years, 75% had a risk-reducing salpingo-oophorectomy. Amongst women who had not had a risk-reducing bilateral mastectomy, only 6% took risk-reducing medication. Fear of side-effects was cited as the main reasons for not taking these medicines by 73% of women. Conclusions Guidelines did not change the percentages of tested patients meeting genetic testing criteria but improved documentation of risk management advice by health professionals. Effective approaches to enhance compliance with guidelines are needed to improve risk management and quality of care. Supplementary Information The online version contains supplementary material available at 10.1186/s13053-021-00180-3.
Collapse
Affiliation(s)
- Bettina Meiser
- Psychosocial Research Group, Prince of Wales Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, NSW, 2052, Australia.
| | - Rajneesh Kaur
- Psychosocial Research Group, Prince of Wales Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, NSW, 2052, Australia
| | - April Morrow
- Psychosocial Research Group, Prince of Wales Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, NSW, 2052, Australia
| | - Michelle Peate
- Psychosocial Research Group, Prince of Wales Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, NSW, 2052, Australia.,Department of Obstetrics and Oncology, Royal Women's Hospital, University of Melbourne, Melbourne, Australia
| | - W K Tim Wong
- Psychosocial Research Group, Prince of Wales Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, NSW, 2052, Australia.,School of Social Sciences, UNSW Sydney, Sydney, Australia
| | - Emily McPike
- Psychosocial Research Group, Prince of Wales Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, NSW, 2052, Australia
| | - Elisa Cops
- Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia
| | - Cassandra Nichols
- Genetic Services of Western Australia, King Edward Memorial Hospital, Perth, Australia
| | - Rachel Austin
- Genetic Health Queensland, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
| | - Miriam Fine
- Adult Genetics Unit, Royal Adelaide Hospital, Adelaide and School of Medicine, University of Adelaide, Adelaide, Australia
| | - Letitia Thrupp
- Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia
| | - Robyn Ward
- University of Queensland, Brisbane, Australia.,University of Sydney, Faculty of Medicine and Health, Sydney, Australia
| | - Finlay Macrae
- Department of Medicine, Royal Melbourne Hospital, Melbourne, Australia.,Department of Colorectal Medicine and Genetics, University of Melbourne, Melbourne, Australia
| | - Janet E Hiller
- Swinburne University of Technology, Hawthorn, Australia.,School of Public Health, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia
| | - Alison H Trainer
- Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.,The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia
| | - Gillian Mitchell
- Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.,The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia
| | | |
Collapse
|
3
|
Parsons MT, Tudini E, Li H, Hahnen E, Wappenschmidt B, Feliubadaló L, Aalfs CM, Agata S, Aittomäki K, Alducci E, Alonso‐Cerezo MC, Arnold N, Auber B, Austin R, Azzollini J, Balmaña J, Barbieri E, Bartram CR, Blanco A, Blümcke B, Bonache S, Bonanni B, Borg Å, Bortesi B, Brunet J, Bruzzone C, Bucksch K, Cagnoli G, Caldés T, Caliebe A, Caligo MA, Calvello M, Capone GL, Caputo SM, Carnevali I, Carrasco E, Caux‐Moncoutier V, Cavalli P, Cini G, Clarke EM, Concolino P, Cops EJ, Cortesi L, Couch FJ, Darder E, de la Hoya M, Dean M, Debatin I, Del Valle J, Delnatte C, Derive N, Diez O, Ditsch N, Domchek SM, Dutrannoy V, Eccles DM, Ehrencrona H, Enders U, Evans DG, Farra C, Faust U, Felbor U, Feroce I, Fine M, Foulkes WD, Galvao HC, Gambino G, Gehrig A, Gensini F, Gerdes A, Germani A, Giesecke J, Gismondi V, Gómez C, Gómez Garcia EB, González S, Grau E, Grill S, Gross E, Guerrieri‐Gonzaga A, Guillaud‐Bataille M, Gutiérrez‐Enríquez S, Haaf T, Hackmann K, Hansen TV, Harris M, Hauke J, Heinrich T, Hellebrand H, Herold KN, Honisch E, Horvath J, Houdayer C, Hübbel V, Iglesias S, Izquierdo A, James PA, Janssen LA, Jeschke U, Kaulfuß S, Keupp K, Kiechle M, Kölbl A, Krieger S, Kruse TA, Kvist A, Lalloo F, Larsen M, Lattimore VL, Lautrup C, Ledig S, Leinert E, Lewis AL, Lim J, Loeffler M, López‐Fernández A, Lucci‐Cordisco E, Maass N, Manoukian S, Marabelli M, Matricardi L, Meindl A, Michelli RD, Moghadasi S, Moles‐Fernández A, Montagna M, Montalban G, Monteiro AN, Montes E, Mori L, Moserle L, Müller CR, Mundhenke C, Naldi N, Nathanson KL, Navarro M, Nevanlinna H, Nichols CB, Niederacher D, Nielsen HR, Ong K, Pachter N, Palmero EI, Papi L, Pedersen IS, Peissel B, Perez‐Segura P, Pfeifer K, Pineda M, Pohl‐Rescigno E, Poplawski NK, Porfirio B, Quante AS, Ramser J, Reis RM, Revillion F, Rhiem K, Riboli B, Ritter J, Rivera D, Rofes P, Rump A, Salinas M, Sánchez de Abajo AM, Schmidt G, Schoenwiese U, Seggewiß J, Solanes A, Steinemann D, Stiller M, Stoppa‐Lyonnet D, Sullivan KJ, Susman R, Sutter C, Tavtigian SV, Teo SH, Teulé A, Thomassen M, Tibiletti MG, Tischkowitz M, Tognazzo S, Toland AE, Tornero E, Törngren T, Torres‐Esquius S, Toss A, Trainer AH, Tucker KM, van Asperen CJ, van Mackelenbergh MT, Varesco L, Vargas‐Parra G, Varon R, Vega A, Velasco Á, Vesper A, Viel A, Vreeswijk MPG, Wagner SA, Waha A, Walker LC, Walters RJ, Wang‐Gohrke S, Weber BHF, Weichert W, Wieland K, Wiesmüller L, Witzel I, Wöckel A, Woodward ER, Zachariae S, Zampiga V, Zeder‐Göß C, Investigators KC, Lázaro C, De Nicolo A, Radice P, Engel C, Schmutzler RK, Goldgar DE, Spurdle AB. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification. Hum Mutat 2019; 40:1557-1578. [PMID: 31131967 PMCID: PMC6772163 DOI: 10.1002/humu.23818] [Citation(s) in RCA: 84] [Impact Index Per Article: 16.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2019] [Revised: 05/08/2019] [Accepted: 05/12/2019] [Indexed: 12/24/2022]
Abstract
The multifactorial likelihood analysis method has demonstrated utility for quantitative assessment of variant pathogenicity for multiple cancer syndrome genes. Independent data types currently incorporated in the model for assessing BRCA1 and BRCA2 variants include clinically calibrated prior probability of pathogenicity based on variant location and bioinformatic prediction of variant effect, co-segregation, family cancer history profile, co-occurrence with a pathogenic variant in the same gene, breast tumor pathology, and case-control information. Research and clinical data for multifactorial likelihood analysis were collated for 1,395 BRCA1/2 predominantly intronic and missense variants, enabling classification based on posterior probability of pathogenicity for 734 variants: 447 variants were classified as (likely) benign, and 94 as (likely) pathogenic; and 248 classifications were new or considerably altered relative to ClinVar submissions. Classifications were compared with information not yet included in the likelihood model, and evidence strengths aligned to those recommended for ACMG/AMP classification codes. Altered mRNA splicing or function relative to known nonpathogenic variant controls were moderately to strongly predictive of variant pathogenicity. Variant absence in population datasets provided supporting evidence for variant pathogenicity. These findings have direct relevance for BRCA1 and BRCA2 variant evaluation, and justify the need for gene-specific calibration of evidence types used for variant classification.
Collapse
Affiliation(s)
- Michael T. Parsons
- Department of Genetics and Computational BiologyQIMR Berghofer Medical Research InstituteBrisbaneQueenslandAustralia
| | - Emma Tudini
- Department of Genetics and Computational BiologyQIMR Berghofer Medical Research InstituteBrisbaneQueenslandAustralia
| | - Hongyan Li
- Cancer Control and Population Science, Huntsman Cancer InstituteUniversity of UtahSalt Lake CityUtah
| | - Eric Hahnen
- Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital CologneUniversity of CologneCologneGermany
- Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital CologneUniversity of CologneCologneGermany
| | - Barbara Wappenschmidt
- Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital CologneUniversity of CologneCologneGermany
- Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital CologneUniversity of CologneCologneGermany
| | - Lidia Feliubadaló
- Hereditary Cancer Program, ONCOBELL‐IDIBELL‐IDIBGI‐IGTP, Catalan Institute of OncologyCIBERONCBarcelonaSpain
| | - Cora M. Aalfs
- Department of Clinical GeneticsAmsterdam UMCAmsterdamThe Netherlands
| | - Simona Agata
- Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOVIRCCSPaduaItaly
| | - Kristiina Aittomäki
- Department of Clinical Genetics, Helsinki University HospitalUniversity of HelsinkiHelsinkiFinland
| | - Elisa Alducci
- Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOVIRCCSPaduaItaly
| | | | - Norbert Arnold
- Department of Gynaecology and Obstetrics, University Hospital of Schleswig‐Holstein, Campus KielChristian‐Albrechts University KielKielGermany
- Institute of Clinical Molecular Biology, University Hospital of Schleswig‐Holstein, Campus KielChristian‐Albrechts University KielKielGermany
| | - Bernd Auber
- Institute of Human GeneticsHannover Medical SchoolHannoverGermany
| | - Rachel Austin
- Genetic Health QueenslandRoyal Brisbane and Women's HospitalBrisbaneAustralia
| | - Jacopo Azzollini
- Unit of Medical Genetics, Department of Medical Oncology and HematologyFondazione IRCCS Istituto Nazionale dei Tumori di MilanoMilanItaly
| | - Judith Balmaña
- High Risk and Cancer Prevention GroupVall d'Hebron Institute of OncologyBarcelonaSpain
- Department of Medical OncologyUniversity Hospital of Vall d'HebronBarcelonaSpain
| | - Elena Barbieri
- Department of Oncology and HaematologyUniversity of Modena and Reggio EmiliaModenaItaly
| | - Claus R. Bartram
- Institute of Human GeneticsUniversity Hospital HeidelbergHeidelbergGermany
| | - Ana Blanco
- Fundación Pública galega Medicina Xenómica‐SERGASGrupo de Medicina Xenómica‐USC, CIBERER, IDISSantiago de CompostelaSpain
| | - Britta Blümcke
- Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital CologneUniversity of CologneCologneGermany
- Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital CologneUniversity of CologneCologneGermany
| | - Sandra Bonache
- Oncogenetics GroupVall d'Hebron Institute of Oncology (VHIO)BarcelonaSpain
| | - Bernardo Bonanni
- Division of Cancer Prevention and Genetics, IEOEuropean Institute of Oncology IRCCSMilanItaly
| | - Åke Borg
- Division of Oncology and Pathology, Department of Clinical Sciences LundLund UniversityLundSweden
| | | | - Joan Brunet
- Hereditary Cancer Program, ONCOBELL‐IDIBELL‐IDIBGI‐IGTP, Catalan Institute of OncologyCIBERONCBarcelonaSpain
| | - Carla Bruzzone
- Unit of Hereditary CancerIRCCS Ospedale Policlinico San MartinoGenoaItaly
| | - Karolin Bucksch
- Institute for Medical Informatics, Statistics and EpidemiologyUniversity of LeipzigLeipzigGermany
| | - Giulia Cagnoli
- Unit of Medical Genetics, Department of Medical Oncology and HematologyFondazione IRCCS Istituto Nazionale dei Tumori di MilanoMilanItaly
| | - Trinidad Caldés
- Molecular Oncology Laboratory, CIBERONC, Hospital Clinico San CarlosIdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos)MadridSpain
| | - Almuth Caliebe
- Institute of Human Genetics, University Hospital of Schleswig‐Holstein, Campus KielChristian‐Albrechts University KielKielGermany
| | | | - Mariarosaria Calvello
- Division of Cancer Prevention and Genetics, IEOEuropean Institute of Oncology IRCCSMilanItaly
| | - Gabriele L. Capone
- Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', Medical Genetics UnitUniversity of FlorenceFlorenceItaly
| | - Sandrine M. Caputo
- Service de GénétiqueInstitut CurieParisFrance
- Paris Sciences Lettres Research UniversityParisFrance
| | - Ileana Carnevali
- UO Anatomia PatologicaOspedale di Circolo ASST SettelaghiVareseItaly
| | - Estela Carrasco
- High Risk and Cancer Prevention GroupVall d'Hebron Institute of OncologyBarcelonaSpain
| | | | | | - Giulia Cini
- Division of Functional Onco‐genomics and Genetics, Centro di Riferimento Oncologico di Aviano (CRO)IRCCSAvianoItaly
| | - Edward M. Clarke
- Department of Genetics and Computational BiologyQIMR Berghofer Medical Research InstituteBrisbaneQueenslandAustralia
| | - Paola Concolino
- Fondazione Policlinico Universitario A.GemelliIRCCSRomeItaly
| | - Elisa J. Cops
- Parkville Familial Cancer CentrePeter MacCallum Cancer CenterMelbourneVictoriaAustralia
| | - Laura Cortesi
- Department of Oncology and HaematologyUniversity of Modena and Reggio EmiliaModenaItaly
| | - Fergus J. Couch
- Department of Laboratory Medicine and PathologyMayo ClinicRochesterMinnesota
| | - Esther Darder
- Hereditary Cancer Program, ONCOBELL‐IDIBELL‐IDIBGI‐IGTP, Catalan Institute of OncologyCIBERONCBarcelonaSpain
| | - Miguel de la Hoya
- Molecular Oncology Laboratory, CIBERONC, Hospital Clinico San CarlosIdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos)MadridSpain
| | - Michael Dean
- Laboratory of Translational Genomics, DCEGNational Cancer InstituteGaithersburgMaryland
| | - Irmgard Debatin
- Institute of Human GeneticsUniversity Hospital UlmUlmGermany
| | - Jesús Del Valle
- Hereditary Cancer Program, ONCOBELL‐IDIBELL‐IDIBGI‐IGTP, Catalan Institute of OncologyCIBERONCBarcelonaSpain
| | | | - Nicolas Derive
- Service de GénétiqueInstitut CurieParisFrance
- Paris Sciences Lettres Research UniversityParisFrance
| | - Orland Diez
- Oncogenetics GroupVall d'Hebron Institute of Oncology (VHIO)BarcelonaSpain
- Clinical and Molecular Genetics AreaUniversity Hospital Vall d'HebronBarcelonaSpain
| | - Nina Ditsch
- Department of Gynecology and ObstetricsUniversity of MunichMunichGermany
| | - Susan M. Domchek
- Basser Center for BRCA, Abramson Cancer CenterUniversity of PennsylvaniaPhiladelphiaPennsylvania
| | - Véronique Dutrannoy
- Institute of Medical and Human GeneticsCharité –Universitätsmedizin BerlinBerlinGermany
| | | | - Hans Ehrencrona
- Department of Clinical Genetics and Pathology, Laboratory MedicineOffice for Medical Services ‐ Region SkåneLundSweden
- Division of Clinical Genetics, Department of Laboratory MedicineLund UniversityLundSweden
| | - Ute Enders
- Institute for Medical Informatics, Statistics and EpidemiologyUniversity of LeipzigLeipzigGermany
| | - D. Gareth Evans
- Genomic Medicine, Division of Evolution and Genomic Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester Universities Foundation TrustSt. Mary's HospitalManchesterUK
- Genomic Medicine, North West Genomics hub, Manchester Academic Health Science Centre, Manchester Universities Foundation TrustSt. Mary's HospitalManchesterUK
| | - Chantal Farra
- Medical GeneticsAmerican University of Beirut Medical CenterBeirutLebanon
| | - Ulrike Faust
- Institute of Medical Genetics and Applied GenomicsUniversity of TübingenTübingenGermany
| | - Ute Felbor
- Institute of Human GeneticsUniversity Medicine GreifswaldGreifswaldGermany
| | - Irene Feroce
- Division of Cancer Prevention and Genetics, IEOEuropean Institute of Oncology IRCCSMilanItaly
| | - Miriam Fine
- Adult Genetics UnitRoyal Adelaide HospitalAdelaideAustralia
| | - William D. Foulkes
- Program in Cancer Genetics, Departments of Human Genetics and OncologyMcGill UniversityMontréalQCCanada
| | | | | | - Andrea Gehrig
- Department of Human GeneticsUniversity of WürzburgWürzburgGermany
| | - Francesca Gensini
- Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', Medical Genetics UnitUniversity of FlorenceFlorenceItaly
| | - Anne‐Marie Gerdes
- Department of Clinical Genetics, RigshospitaletCopenhagen University HospitalCopenhagenDenmark
| | - Aldo Germani
- Department of Clinical and Molecular Medicine, Sant'Andrea University HospitalSapienza UniversityRomeItaly
| | - Jutta Giesecke
- Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital CologneUniversity of CologneCologneGermany
- Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital CologneUniversity of CologneCologneGermany
| | - Viviana Gismondi
- Unit of Hereditary CancerIRCCS Ospedale Policlinico San MartinoGenoaItaly
| | - Carolina Gómez
- Hereditary Cancer Program, ONCOBELL‐IDIBELL‐IDIBGI‐IGTP, Catalan Institute of OncologyCIBERONCBarcelonaSpain
| | - Encarna B. Gómez Garcia
- Department of Clinical GeneticsMaastricht University Medical CenterMaastrichtThe Netherlands
| | - Sara González
- Hereditary Cancer Program, ONCOBELL‐IDIBELL‐IDIBGI‐IGTP, Catalan Institute of OncologyCIBERONCBarcelonaSpain
| | - Elia Grau
- Hereditary Cancer Program, ONCOBELL‐IDIBELL‐IDIBGI‐IGTP, Catalan Institute of OncologyCIBERONCBarcelonaSpain
| | - Sabine Grill
- Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der TechnischenUniversität MünchenMunichGermany
| | - Eva Gross
- Department of Gynecology and ObstetricsUniversity of MunichMunichGermany
| | | | | | | | - Thomas Haaf
- Department of Human GeneticsUniversity of WürzburgWürzburgGermany
| | - Karl Hackmann
- Institute for Clinical Genetics, Faculty of Medicine Carl Gustav CarusTU DresdenDresdenGermany
| | - Thomas V.O. Hansen
- Department of Clinical Genetics, RigshospitaletCopenhagen University HospitalCopenhagenDenmark
| | | | - Jan Hauke
- Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital CologneUniversity of CologneCologneGermany
- Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital CologneUniversity of CologneCologneGermany
| | - Tilman Heinrich
- Institute of Medical Genetics and Applied GenomicsUniversity of TübingenTübingenGermany
| | - Heide Hellebrand
- Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der TechnischenUniversität MünchenMunichGermany
| | | | - Ellen Honisch
- Department of Gynecology and Obstetrics, University Hospital DüsseldorfHeinrich‐Heine University DüsseldorfDüsseldorfGermany
| | - Judit Horvath
- Institute of Human GeneticsUniversity of MünsterMünsterGermany
| | - Claude Houdayer
- Department of Genetics, F76000 and Normandy University, UNIROUEN, Inserm U1245, Normandy Centre for Genomic and Personalized MedicineRouen University HospitalRouenFrance
| | - Verena Hübbel
- Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital CologneUniversity of CologneCologneGermany
- Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital CologneUniversity of CologneCologneGermany
| | - Silvia Iglesias
- Hereditary Cancer Program, ONCOBELL‐IDIBELL‐IDIBGI‐IGTP, Catalan Institute of OncologyCIBERONCBarcelonaSpain
| | - Angel Izquierdo
- Hereditary Cancer Program, ONCOBELL‐IDIBELL‐IDIBGI‐IGTP, Catalan Institute of OncologyCIBERONCBarcelonaSpain
| | - Paul A. James
- Parkville Familial Cancer CentrePeter MacCallum Cancer CenterMelbourneVictoriaAustralia
- Sir Peter MacCallum Department of OncologyThe University of MelbourneMelbourneVictoriaAustralia
| | - Linda A.M. Janssen
- Department of Clinical GeneticsLeiden University Medical CenterLeidenThe Netherlands
| | - Udo Jeschke
- Department of Gynecology and ObstetricsUniversity of MunichMunichGermany
| | - Silke Kaulfuß
- Institute of Human GeneticsUniversity Medical Center GöttingenGöttingenGermany
| | - Katharina Keupp
- Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital CologneUniversity of CologneCologneGermany
- Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital CologneUniversity of CologneCologneGermany
| | - Marion Kiechle
- Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der TechnischenUniversität MünchenMunichGermany
| | - Alexandra Kölbl
- Department of Gynecology and ObstetricsUniversity of MunichMunichGermany
| | - Sophie Krieger
- Laboratoire de Biologie Clinique et OncologiqueCentre Francois BaclesseCaenFrance
- Genomics and Personalized Medecine in Cancer and Neurological DisordersNormandy Centre for Genomic and Personalized MedicineRouenFrance
- Normandie UniversitéUNICAENCaenFrance
| | - Torben A. Kruse
- Department of Clinical GeneticsOdense University HospitalOdense CDenmark
| | - Anders Kvist
- Division of Oncology and Pathology, Department of Clinical Sciences LundLund UniversityLundSweden
| | - Fiona Lalloo
- Genomic Medicine, North West Genomics hub, Manchester Academic Health Science Centre, Manchester Universities Foundation TrustSt. Mary's HospitalManchesterUK
| | - Mirjam Larsen
- Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital CologneUniversity of CologneCologneGermany
- Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital CologneUniversity of CologneCologneGermany
| | - Vanessa L. Lattimore
- Department of Pathology and Biomedical ScienceUniversity of OtagoChristchurchNew Zealand
| | - Charlotte Lautrup
- Department of Clinical GeneticsAalborg University HospitalAalborgDenmark
- Clinical Cancer Research CenterAalborg University HospitalAalborgDenmark
| | - Susanne Ledig
- Institute of Human GeneticsUniversity of MünsterMünsterGermany
| | - Elena Leinert
- Department of Gynaecology and ObstetricsUniversity Hospital UlmUlmGermany
| | | | - Joanna Lim
- Breast Cancer Research ProgrammeCancer Research MalaysiaSubang JayaSelangorMalaysia
| | - Markus Loeffler
- Institute for Medical Informatics, Statistics and EpidemiologyUniversity of LeipzigLeipzigGermany
| | - Adrià López‐Fernández
- High Risk and Cancer Prevention GroupVall d'Hebron Institute of OncologyBarcelonaSpain
| | - Emanuela Lucci‐Cordisco
- UOC Genetica Medica, Fondazione Policlinico Universitario A.Gemelli IRCCS and Istituto di Medicina GenomicaUniversità Cattolica del Sacro CuoreRomeItaly
| | - Nicolai Maass
- Department of Gynaecology and Obstetrics, University Hospital of Schleswig‐Holstein, Campus KielChristian‐Albrechts University KielKielGermany
| | - Siranoush Manoukian
- Unit of Medical Genetics, Department of Medical Oncology and HematologyFondazione IRCCS Istituto Nazionale dei Tumori di MilanoMilanItaly
| | - Monica Marabelli
- Division of Cancer Prevention and Genetics, IEOEuropean Institute of Oncology IRCCSMilanItaly
| | - Laura Matricardi
- Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOVIRCCSPaduaItaly
| | - Alfons Meindl
- Department of Gynecology and ObstetricsUniversity of MunichMunichGermany
| | | | - Setareh Moghadasi
- Department of Clinical GeneticsLeiden University Medical CenterLeidenThe Netherlands
| | | | - Marco Montagna
- Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOVIRCCSPaduaItaly
| | - Gemma Montalban
- Oncogenetics GroupVall d'Hebron Institute of Oncology (VHIO)BarcelonaSpain
| | | | - Eva Montes
- Hereditary Cancer Program, ONCOBELL‐IDIBELL‐IDIBGI‐IGTP, Catalan Institute of OncologyCIBERONCBarcelonaSpain
| | - Luigi Mori
- Department of Clinical and Experimental Science, University of Brescia c/o 2nd Internal MedicineHospital of BresciaBresciaItaly
| | - Lidia Moserle
- Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOVIRCCSPaduaItaly
| | | | - Christoph Mundhenke
- Department of Gynaecology and Obstetrics, University Hospital of Schleswig‐Holstein, Campus KielChristian‐Albrechts University KielKielGermany
| | - Nadia Naldi
- Division of OncologyUniversity Hospital of ParmaParmaItaly
| | - Katherine L. Nathanson
- Basser Center for BRCA, Abramson Cancer CenterUniversity of PennsylvaniaPhiladelphiaPennsylvania
| | - Matilde Navarro
- Hereditary Cancer Program, ONCOBELL‐IDIBELL‐IDIBGI‐IGTP, Catalan Institute of OncologyCIBERONCBarcelonaSpain
| | - Heli Nevanlinna
- Department of Obstetrics and Gynecology, Helsinki University HospitalUniversity of HelsinkiHelsinkiFinland
| | - Cassandra B. Nichols
- Genetic Services of Western AustraliaKing Edward Memorial HospitalPerthAustralia
| | - Dieter Niederacher
- Department of Gynecology and Obstetrics, University Hospital DüsseldorfHeinrich‐Heine University DüsseldorfDüsseldorfGermany
| | | | - Kai‐ren Ong
- West Midlands Regional Genetics ServiceBirmingham Women's Hospital Healthcare NHS TrustBirminghamUK
| | - Nicholas Pachter
- Genetic Services of Western AustraliaKing Edward Memorial HospitalPerthAustralia
- Faculty of Health and Medical SciencesUniversity of Western AustraliaPerthAustralia
| | - Edenir I. Palmero
- Molecular Oncology Research CenterBarretos Cancer HospitalSão PauloBrazil
- Barretos School of Health SciencesDr. Paulo Prata ‐ FACISBSão PauloBrazil
| | - Laura Papi
- Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', Medical Genetics UnitUniversity of FlorenceFlorenceItaly
| | - Inge Sokilde Pedersen
- Clinical Cancer Research CenterAalborg University HospitalAalborgDenmark
- Molecular DiagnosticsAalborg University HospitalAalborgDenmark
- Department of Clinical MedicineAalborg UniversityAalborgDenmark
| | - Bernard Peissel
- Unit of Medical Genetics, Department of Medical Oncology and HematologyFondazione IRCCS Istituto Nazionale dei Tumori di MilanoMilanItaly
| | - Pedro Perez‐Segura
- Molecular Oncology Laboratory, CIBERONC, Hospital Clinico San CarlosIdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos)MadridSpain
| | - Katharina Pfeifer
- Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der TechnischenUniversität MünchenMunichGermany
| | - Marta Pineda
- Hereditary Cancer Program, ONCOBELL‐IDIBELL‐IDIBGI‐IGTP, Catalan Institute of OncologyCIBERONCBarcelonaSpain
| | - Esther Pohl‐Rescigno
- Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital CologneUniversity of CologneCologneGermany
- Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital CologneUniversity of CologneCologneGermany
| | - Nicola K. Poplawski
- Adult Genetics UnitRoyal Adelaide HospitalAdelaideAustralia
- School of Paediatrics and Reproductive HealthUniversity of AdelaideAdelaideAustralia
| | - Berardino Porfirio
- Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', Medical Genetics UnitUniversity of FlorenceFlorenceItaly
| | - Anne S. Quante
- Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der TechnischenUniversität MünchenMunichGermany
| | - Juliane Ramser
- Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der TechnischenUniversität MünchenMunichGermany
| | - Rui M. Reis
- Molecular Oncology Research CenterBarretos Cancer HospitalSão PauloBrazil
- Health Sciences SchoolUniversity of MinhoBragaPortugal
- ICVS/3B's‐PT Government Associate LaboratoryBragaPortugal
| | - Françoise Revillion
- Laboratoire d'Oncogenetique Moleculaire HumaineCentre Oscar LambretLilleFrance
| | - Kerstin Rhiem
- Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital CologneUniversity of CologneCologneGermany
- Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital CologneUniversity of CologneCologneGermany
| | | | - Julia Ritter
- Institute of Medical and Human GeneticsCharité –Universitätsmedizin BerlinBerlinGermany
| | - Daniela Rivera
- Unit of Hereditary CancerIRCCS Ospedale Policlinico San MartinoGenoaItaly
| | - Paula Rofes
- Hereditary Cancer Program, ONCOBELL‐IDIBELL‐IDIBGI‐IGTP, Catalan Institute of OncologyCIBERONCBarcelonaSpain
| | - Andreas Rump
- Institute for Clinical Genetics, Faculty of Medicine Carl Gustav CarusTU DresdenDresdenGermany
| | - Monica Salinas
- Hereditary Cancer Program, ONCOBELL‐IDIBELL‐IDIBGI‐IGTP, Catalan Institute of OncologyCIBERONCBarcelonaSpain
| | - Ana María Sánchez de Abajo
- Servicio de Análisis Clínicos y Bioquímica Clínica, Complejo HospitalarioUniversitario Insular Materno‐Infantil de Gran CanariaLas Palmas de Gran CanaríaSpain
| | - Gunnar Schmidt
- Institute of Human GeneticsHannover Medical SchoolHannoverGermany
| | - Ulrike Schoenwiese
- Institute for Medical Informatics, Statistics and EpidemiologyUniversity of LeipzigLeipzigGermany
| | - Jochen Seggewiß
- Institute of Human GeneticsUniversity of MünsterMünsterGermany
| | - Ares Solanes
- Hereditary Cancer Program, ONCOBELL‐IDIBELL‐IDIBGI‐IGTP, Catalan Institute of OncologyCIBERONCBarcelonaSpain
| | - Doris Steinemann
- Institute of Human GeneticsHannover Medical SchoolHannoverGermany
| | - Mathias Stiller
- Institute of Human GeneticsUniversity Hospital LeipzigLeipzigGermany
| | - Dominique Stoppa‐Lyonnet
- Service de GénétiqueInstitut CurieParisFrance
- Department of Tumour BiologyINSERM U830ParisFrance
- Université Paris DescartesParisFrance
| | - Kelly J. Sullivan
- Genetic Health Service NZ‐ Northern HubAuckland District Health BoardAucklandNew Zealand
| | - Rachel Susman
- Genetic Health QueenslandRoyal Brisbane and Women's HospitalBrisbaneAustralia
| | - Christian Sutter
- Institute of Human GeneticsUniversity Hospital HeidelbergHeidelbergGermany
| | - Sean V. Tavtigian
- Department of Oncological ServicesUniversity of Utah School of MedicineSalt Lake CityUtah
- Huntsman Cancer InstituteUniversity of UtahSalt Lake CityUtah
| | - Soo H. Teo
- Breast Cancer Research ProgrammeCancer Research MalaysiaSubang JayaSelangorMalaysia
- Department of Surgery, Faculty of MedicineUniversity MalayaKuala LumpurMalaysia
| | - Alex Teulé
- Hereditary Cancer Program, ONCOBELL‐IDIBELL‐IDIBGI‐IGTP, Catalan Institute of OncologyCIBERONCBarcelonaSpain
| | - Mads Thomassen
- Department of Clinical GeneticsOdense University HospitalOdense CDenmark
| | | | - Marc Tischkowitz
- Department of Medical GeneticsUniversity of CambridgeCambridgeUK
| | - Silvia Tognazzo
- Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOVIRCCSPaduaItaly
| | - Amanda E. Toland
- Department of Cancer Biology and GeneticsThe Ohio State UniversityColumbusOhio
| | - Eva Tornero
- Hereditary Cancer Program, ONCOBELL‐IDIBELL‐IDIBGI‐IGTP, Catalan Institute of OncologyCIBERONCBarcelonaSpain
| | - Therese Törngren
- Division of Oncology and Pathology, Department of Clinical Sciences LundLund UniversityLundSweden
| | - Sara Torres‐Esquius
- High Risk and Cancer Prevention GroupVall d'Hebron Institute of OncologyBarcelonaSpain
| | - Angela Toss
- Department of Oncology and HaematologyUniversity of Modena and Reggio EmiliaModenaItaly
| | - Alison H. Trainer
- Parkville Familial Cancer CentrePeter MacCallum Cancer CenterMelbourneVictoriaAustralia
- Department of medicineUniversity of MelbourneMelbourneVictoriaAustralia
| | - Katherine M. Tucker
- Prince of Wales Clinical SchoolUniversity of NSWSydneyNew South WalesAustralia
- Hereditary Cancer Clinic, Department of Medical OncologyPrince of Wales HospitalRandwickNew South WalesAustralia
| | | | - Marion T. van Mackelenbergh
- Department of Gynaecology and Obstetrics, University Hospital of Schleswig‐Holstein, Campus KielChristian‐Albrechts University KielKielGermany
| | - Liliana Varesco
- Unit of Hereditary CancerIRCCS Ospedale Policlinico San MartinoGenoaItaly
| | - Gardenia Vargas‐Parra
- Hereditary Cancer Program, ONCOBELL‐IDIBELL‐IDIBGI‐IGTP, Catalan Institute of OncologyCIBERONCBarcelonaSpain
| | - Raymonda Varon
- Institute of Medical and Human GeneticsCharité –Universitätsmedizin BerlinBerlinGermany
| | - Ana Vega
- Fundación Pública galega Medicina Xenómica‐SERGASGrupo de Medicina Xenómica‐USC, CIBERER, IDISSantiago de CompostelaSpain
| | - Ángela Velasco
- Hereditary Cancer Program, ONCOBELL‐IDIBELL‐IDIBGI‐IGTP, Catalan Institute of OncologyCIBERONCBarcelonaSpain
| | - Anne‐Sophie Vesper
- Department of Gynecology and Obstetrics, University Hospital DüsseldorfHeinrich‐Heine University DüsseldorfDüsseldorfGermany
| | - Alessandra Viel
- Division of Functional Onco‐genomics and Genetics, Centro di Riferimento Oncologico di Aviano (CRO)IRCCSAvianoItaly
| | | | - Sebastian A. Wagner
- Department of MedicineHematology/Oncology, Goethe‐University FrankfurtFrankfurtGermany
| | - Anke Waha
- Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital CologneUniversity of CologneCologneGermany
- Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital CologneUniversity of CologneCologneGermany
| | - Logan C. Walker
- Department of Pathology and Biomedical ScienceUniversity of OtagoChristchurchNew Zealand
| | - Rhiannon J. Walters
- Department of Genetics and Computational BiologyQIMR Berghofer Medical Research InstituteBrisbaneQueenslandAustralia
| | - Shan Wang‐Gohrke
- Department of Gynaecology and ObstetricsUniversity Hospital UlmUlmGermany
| | | | - Wilko Weichert
- Institute of PathologyTechnische Universität MünchenMunichGermany
| | - Kerstin Wieland
- Institute for Medical Informatics, Statistics and EpidemiologyUniversity of LeipzigLeipzigGermany
| | - Lisa Wiesmüller
- Department of Gynaecology and ObstetricsUniversity Hospital UlmUlmGermany
| | - Isabell Witzel
- Department of GynecologyUniversity Medical Center HamburgHamburgGermany
| | - Achim Wöckel
- Department of Gynecology and ObstetricsUniversity Hospital WürzburgWürzburgGermany
| | - Emma R. Woodward
- Genomic Medicine, Division of Evolution and Genomic Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester Universities Foundation TrustSt. Mary's HospitalManchesterUK
- Genomic Medicine, North West Genomics hub, Manchester Academic Health Science Centre, Manchester Universities Foundation TrustSt. Mary's HospitalManchesterUK
| | - Silke Zachariae
- Institute for Medical Informatics, Statistics and EpidemiologyUniversity of LeipzigLeipzigGermany
| | - Valentina Zampiga
- Biosciences LaboratoryIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCSMeldolaItaly
| | | | - KConFab Investigators
- Sir Peter MacCallum Department of OncologyThe University of MelbourneMelbourneVictoriaAustralia
- Research DepartmentPeter MacCallum Cancer CenterMelbourneVictoriaAustralia
| | - Conxi Lázaro
- Hereditary Cancer Program, ONCOBELL‐IDIBELL‐IDIBGI‐IGTP, Catalan Institute of OncologyCIBERONCBarcelonaSpain
| | | | - Paolo Radice
- Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of ResearchFondazione IRCCS Istituto Nazionale dei Tumori (INT)MilanItaly
| | - Christoph Engel
- Institute for Medical Informatics, Statistics and EpidemiologyUniversity of LeipzigLeipzigGermany
| | - Rita K. Schmutzler
- Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital CologneUniversity of CologneCologneGermany
- Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital CologneUniversity of CologneCologneGermany
| | - David E. Goldgar
- Department of Dermatology, Huntsman Cancer InstituteUniversity of Utah School of MedicineSalt Lake CityUtah
| | - Amanda B. Spurdle
- Department of Genetics and Computational BiologyQIMR Berghofer Medical Research InstituteBrisbaneQueenslandAustralia
| |
Collapse
|
4
|
Cattano C, Fine M, Quattrocchi F, Holzman R, Milazzo M. Behavioural responses of fish groups exposed to a predatory threat under elevated CO 2. Mar Environ Res 2019; 147:179-184. [PMID: 31060864 DOI: 10.1016/j.marenvres.2019.04.011] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/23/2019] [Revised: 04/18/2019] [Accepted: 04/23/2019] [Indexed: 06/09/2023]
Abstract
Most of the studies dealing with the effects of ocean acidification (OA) on fish behaviour tested individuals in isolation, even when the examined species live in shoals in the wild. Here we evaluated the effects of elevated CO2 concentrations (i.e. ∼900 μatm) on the shelter use and group cohesion of the gregarious damselfish Chromis viridis using groups of sub-adults exposed to a predatory threat. Results showed that, under predatory threat, fish reared at elevated CO2 concentrations displayed a risky behaviour (i.e. decreased shelter use), whereas their group cohesion was unaffected. Our findings add on increasing evidence to account for social dynamics in OA experiments, as living in groups may compensate for CO2-induced risky behaviour.
Collapse
Affiliation(s)
- C Cattano
- Dipartimento di Scienze della Terra e del Mare (DiSTeM), Università di Palermo, Via Archirafi 20, I-90123, Palermo, Italy; CoNISMa, Piazzale Flaminio 9, 00197, Roma. Italy.
| | - M Fine
- The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, 52900, Israel; The Interuniversity Institute for Marine Sciences, Eilat, 88103, Israel
| | - F Quattrocchi
- Institute for marine biological resources and biotechnologies, Via Vaccara, 61, 91026, Mazara del Vallo, TP, Italy
| | - R Holzman
- The Interuniversity Institute for Marine Sciences, Eilat, 88103, Israel; Department of Zoology, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel
| | - M Milazzo
- Dipartimento di Scienze della Terra e del Mare (DiSTeM), Università di Palermo, Via Archirafi 20, I-90123, Palermo, Italy; CoNISMa, Piazzale Flaminio 9, 00197, Roma. Italy
| |
Collapse
|
5
|
Cheah JJC, Brown AL, Schreiber AW, Feng J, Babic M, Moore S, Young CC, Fine M, Phillips K, Guandalini M, Wilson P, Poplawski N, Hahn CN, Scott HS. A novel germline SAMD9L mutation in a family with ataxia-pancytopenia syndrome and pediatric acute lymphoblastic leukemia. Haematologica 2019; 104:e318-e321. [PMID: 30923096 DOI: 10.3324/haematol.2018.207316] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
Affiliation(s)
- Jesse J C Cheah
- Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA.,Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA.,School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Adelaide, SA
| | - Anna L Brown
- Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA.,Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA.,School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Adelaide, SA.,School of Paediatrics and Reproductive Health, University of Adelaide, Adelaide, SA
| | - Andreas W Schreiber
- School of Biological Sciences, University of Adelaide, Adelaide, SA.,ACRF Cancer Genomics Facility, Centre for Cancer Biology, SA Pathology, Adelaide, SA
| | - Jinghua Feng
- ACRF Cancer Genomics Facility, Centre for Cancer Biology, SA Pathology, Adelaide, SA
| | - Milena Babic
- Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA
| | - Sarah Moore
- Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA
| | - Chun-Chun Young
- Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA
| | - Miriam Fine
- Adult Genetics Unit, Royal Adelaide Hospital, University of Adelaide, Adelaide, SA
| | - Kerry Phillips
- Adult Genetics Unit, Royal Adelaide Hospital, University of Adelaide, Adelaide, SA
| | - Michael Guandalini
- Children's Health Queensland Hospital and Health Service, Lady Cilento Children's Hospital Brisbane, Brisbane, QLD
| | - Peter Wilson
- Children's Cancer Services, Lady Cilento Children's Hospital Brisbane, Brisbane, QLD
| | - Nicola Poplawski
- School of Paediatrics and Reproductive Health, University of Adelaide, Adelaide, SA.,Adult Genetics Unit, Royal Adelaide Hospital, University of Adelaide, Adelaide, SA
| | - Christopher N Hahn
- Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA.,Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA.,School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Adelaide, SA.,School of Medicine, University of Adelaide, Adelaide, SA, Australia
| | - Hamish S Scott
- Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA .,Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA.,School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Adelaide, SA.,School of Biological Sciences, University of Adelaide, Adelaide, SA.,ACRF Cancer Genomics Facility, Centre for Cancer Biology, SA Pathology, Adelaide, SA.,School of Medicine, University of Adelaide, Adelaide, SA, Australia
| |
Collapse
|
6
|
Guardincerri E, Bacon JD, Barros N, Blasi C, Bonechi L, Chen A, D'Alessandro R, Durham JM, Fine M, Mauger C, Mayers G, Morris C, Newcomer FM, Okasinski J, Pizzico T, Plaud-Ramos K, Poulson DC, Reilly MB, Roberts A, Saeid T, Vaccaro V, Van Berg R. Imaging the dome of Santa Maria del Fiore using cosmic rays. Philos Trans A Math Phys Eng Sci 2018; 377:rsta.2018.0136. [PMID: 30530544 PMCID: PMC6335302 DOI: 10.1098/rsta.2018.0136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 10/15/2018] [Indexed: 06/09/2023]
Abstract
The dome of Santa Maria del Fiore, Florence Cathedral, was built between 1420 and 1436 by architect Filippo Brunelleschi and it is now cracking under its own weight. Engineering efforts are under way to model the dome's structure and reinforce it against further deterioration. According to some scholars, Brunelleschi might have built reinforcement structures into the dome itself; however, the only known reinforcement is a wood chain 7.75 m above the springing of the Cupola. Multiple scattering muon radiography is a non-destructive imaging method that can be used to image the interior of the dome's wall and therefore ascertain the layout and status of any iron substructure in it. A demonstration measurement was performed at the Los Alamos National Laboratory on a mock-up wall to show the feasibility of the work proposed, and a lightweight and modular imaging system is currently under construction. We will discuss here the results of the demonstration measurement and the potential of the proposed technique, describe the imaging system under construction and outline the plans for the measurement.This article is part of the Theo Murphy meeting issue 'Cosmic-ray muography'.
Collapse
Affiliation(s)
- E Guardincerri
- Subatomic Physics Group, Los Alamos National Laboratory, PO Box 1663, Los Alamos, NM 87545, USA
| | - J D Bacon
- Subatomic Physics Group, Los Alamos National Laboratory, PO Box 1663, Los Alamos, NM 87545, USA
| | - N Barros
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - C Blasi
- Formerly at University of Parma, Via Università 12, 43121 Parma, Italy
| | - L Bonechi
- INFN - Firenze, Via Sansone 1, Sesto Fiorentino 50019, Italy
| | - A Chen
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - R D'Alessandro
- INFN - Firenze, Via Sansone 1, Sesto Fiorentino 50019, Italy
- Department of Physics and Astronomy, University of Florence, Sesto Fiorentino 50019, Italy
| | - J M Durham
- Subatomic Physics Group, Los Alamos National Laboratory, PO Box 1663, Los Alamos, NM 87545, USA
| | - M Fine
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - C Mauger
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - G Mayers
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - C Morris
- Subatomic Physics Group, Los Alamos National Laboratory, PO Box 1663, Los Alamos, NM 87545, USA
| | - F M Newcomer
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - J Okasinski
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - T Pizzico
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - K Plaud-Ramos
- Subatomic Physics Group, Los Alamos National Laboratory, PO Box 1663, Los Alamos, NM 87545, USA
| | - D C Poulson
- Subatomic Physics Group, Los Alamos National Laboratory, PO Box 1663, Los Alamos, NM 87545, USA
- Department of Nuclear Engineering, University of New Mexico, 1155 University Boulevard SE, Albuquerque, NM 87106-4320, USA
| | - M B Reilly
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - A Roberts
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - T Saeid
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - V Vaccaro
- Opera di Santa Maria del Fiore, Piazza del Duomo 9, 50122 Firenze, Italy
| | - R Van Berg
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, PA 19104, USA
| |
Collapse
|
7
|
Affiliation(s)
- B P Chan
- Gastroenterology, McMaster University, Hamilton, ON, Canada
| | - M Fine
- Gastroenterology, McMaster University, Hamilton, ON, Canada
| | - S Shaffer
- University of Manitoba, Winnipeg, MB, Canada
| |
Collapse
|
8
|
Fine M, Xenodemetropoulos T. A331 BOUVERET’S SYNDROME: A RARE CAUSE OF GASTRIC OUTLET OBSTRUCTION. J Can Assoc Gastroenterol 2018. [DOI: 10.1093/jcag/gwy008.332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- M Fine
- Gastroenterology, McMaster University, Oakville, ON, Canada
| | | |
Collapse
|
9
|
Venugopal P, Moore S, Lawrence DM, George AJ, Hannan RD, Bray SC, To LB, D'Andrea RJ, Feng J, Tirimacco A, Yeoman AL, Young CC, Fine M, Schreiber AW, Hahn CN, Barnett C, Saxon B, Scott HS. Self-reverting mutations partially correct the blood phenotype in a Diamond Blackfan anemia patient. Haematologica 2017; 102:e506-e509. [PMID: 28971907 DOI: 10.3324/haematol.2017.166678] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023] Open
Affiliation(s)
- Parvathy Venugopal
- Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, Australia.,Centre for Cancer Biology, SA Pathology, Adelaide, Australia.,School of Biological Sciences, University of Adelaide, SA 5005, Australia
| | - Sarah Moore
- Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, Australia
| | - David M Lawrence
- School of Biological Sciences, University of Adelaide, SA 5005, Australia.,Australian Cancer Research Foundation Cancer Genomics Facility, Centre for Cancer Biology, SA Pathology, Adelaide, Australia
| | - Amee J George
- ACRF Department of Cancer Biology and Therapeutics, John Curtin School of Medical Research, The Australian National University, Acton, ACT, Australia.,Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.,School of Biomedical Sciences, University of Queensland, St. Lucia, Australia
| | - Ross D Hannan
- ACRF Department of Cancer Biology and Therapeutics, John Curtin School of Medical Research, The Australian National University, Acton, ACT, Australia.,Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.,School of Biomedical Sciences, University of Queensland, St. Lucia, Australia.,Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.,Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia.,Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia
| | - Sarah Ce Bray
- Centre for Cancer Biology, SA Pathology, Adelaide, Australia.,School of Medicine, University of Adelaide, Australia
| | - Luen Bik To
- School of Medicine, University of Adelaide, Australia.,Division of Haematology, SA Pathology, Adelaide, Australia
| | - Richard J D'Andrea
- Centre for Cancer Biology, SA Pathology, Adelaide, Australia.,Division of Haematology, SA Pathology, Adelaide, Australia.,School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Australia
| | - Jinghua Feng
- Australian Cancer Research Foundation Cancer Genomics Facility, Centre for Cancer Biology, SA Pathology, Adelaide, Australia.,School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Australia
| | - Amanda Tirimacco
- Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, Australia
| | - Alexandra L Yeoman
- Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, Australia
| | - Chun Chun Young
- Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, Australia
| | - Miriam Fine
- South Australian Clinical Genetics Service, SA Pathology, Women's and Children's Hospital, North Adelaide, Australia
| | - Andreas W Schreiber
- School of Biological Sciences, University of Adelaide, SA 5005, Australia.,Australian Cancer Research Foundation Cancer Genomics Facility, Centre for Cancer Biology, SA Pathology, Adelaide, Australia.,School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Australia
| | - Christopher N Hahn
- Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, Australia.,Centre for Cancer Biology, SA Pathology, Adelaide, Australia.,School of Medicine, University of Adelaide, Australia.,School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Australia
| | - Christopher Barnett
- School of Medicine, University of Adelaide, Australia.,South Australian Clinical Genetics Service, SA Pathology, Women's and Children's Hospital, North Adelaide, Australia
| | - Ben Saxon
- School of Medicine, University of Adelaide, Australia.,Department of Haematology, SA Pathology, Women's and Children's Hospital, North Adelaide, Australia
| | - Hamish S Scott
- Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, Australia .,Centre for Cancer Biology, SA Pathology, Adelaide, Australia.,School of Biological Sciences, University of Adelaide, SA 5005, Australia.,School of Medicine, University of Adelaide, Australia.,School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Australia
| |
Collapse
|
10
|
Sukerman E, Fine M, Ackerman M, Chen A, Wedlake S, Stosor V. Improving Hepatitis B Vaccination in Heart Transplant Candidates. J Heart Lung Transplant 2017. [DOI: 10.1016/j.healun.2017.01.626] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
11
|
Scott HS, Brown AL, Hiwase D, Schreiber AW, Feng J, Babic M, Poplawski N, Fine M, Rawlings L, Branford S, Fuller S, Lewis I, D’Andrea RJ, Hahn CN. Familial clustering of haematological malignancies: harbingers of wider germline cancer susceptibility. Pathology 2017. [DOI: 10.1016/j.pathol.2016.12.080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
12
|
Hall D, Morrison P, Nikolajski C, Arnold R, Fine M, Zickmund S. Informed Consent to Inguinal Herniorrhaphy and Cholecystectomy: Differences Between What Surgeons Say They Discuss and What They Actually Do Discuss. J Surg Res 2013. [DOI: 10.1016/j.jss.2012.10.751] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
13
|
Fine M, Clark J, Forton J, Doull I. WS3.8 The effect of socioeconomic deprivation on clinical outcomes in cystic fibrosis. J Cyst Fibros 2012. [DOI: 10.1016/s1569-1993(12)60026-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
14
|
|
15
|
Fine M, Mirheydar H, Jon P, Antoine M. The effects of varicocelectomy on men with azospermia and severe oligospermia: a retrospective review and meta-analysis. Fertil Steril 2008. [DOI: 10.1016/j.fertnstert.2008.07.325] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
16
|
Abstract
Recently, reports of coral disease have increased significantly across the world's tropical oceans. Despite increasing efforts to understand the changing incidence of coral disease, very few primary pathogens have been identified, and most studies remain dependent on the external appearance of corals for diagnosis. Given this situation, our current understanding of coral disease and the progression and underlying causes thereof is very limited. In the present study, we use structural and microbial studies to differentiate different forms of black band disease: atypical black band disease and typical black band disease. Atypical black band diseased corals were infected with the black band disease microbial consortium yet did not show any of the typical external signs of black band disease based on macroscopic observations. In previous studies, these examples, here referred to as atypical black band disease, would have not been correctly diagnosed. We also differentiate white syndrome from white diseases on the basis of tissue structure and the presence/absence of microbial associates. White diseases are those with dense bacterial communities associated with lesions of symbiont loss and/or extensive necrosis of tissues, while white syndromes are characteristically bacterium free, with evidence for extensive programmed cell death/apoptosis associated with the lesion and the adjacent tissues. The pathology of coral disease as a whole requires further investigation. This study emphasizes the importance of going beyond the external macroscopic signs of coral disease for accurate disease diagnosis.
Collapse
Affiliation(s)
- T D Ainsworth
- Centre for Marine Studies, University of Queensland, Brisbane 4072, Australia.
| | | | | | | | | |
Collapse
|
17
|
Ainsworth TD, Fine M, Blackall LL, Hoegh-Guldberg O. Fluorescence in situ hybridization and spectral imaging of coral-associated bacterial communities. Appl Environ Microbiol 2006; 72:3016-20. [PMID: 16598010 PMCID: PMC1449077 DOI: 10.1128/aem.72.4.3016-3020.2006] [Citation(s) in RCA: 48] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Microbial communities play important roles in the functioning of coral reef communities. However, extensive autofluorescence of coral tissues and endosymbionts limits the application of standard fluorescence in situ hybridization (FISH) techniques for the identification of the coral-associated bacterial communities. This study overcomes these limitations by combining FISH and spectral imaging.
Collapse
Affiliation(s)
- T D Ainsworth
- Centre for Marine Studies, The University of Queensland, St. Lucia, Brisbane, QLD 4072, Australia.
| | | | | | | |
Collapse
|
18
|
Abbott B, Abbott R, Adhikari R, Ageev A, Allen B, Amin R, Anderson SB, Anderson WG, Araya M, Armandula H, Ashley M, Asiri F, Aufmuth P, Aulbert C, Babak S, Balasubramanian R, Ballmer S, Barish BC, Barker C, Barker D, Barnes M, Barr B, Barton MA, Bayer K, Beausoleil R, Belczynski K, Bennett R, Berukoff SJ, Betzwieser J, Bhawal B, Bilenko IA, Billingsley G, Black E, Blackburn K, Blackburn L, Bland B, Bochner B, Bogue L, Bork R, Bose S, Brady PR, Braginsky VB, Brau JE, Brown DA, Bullington A, Bunkowski A, Buonanno A, Burgess R, Busby D, Butler WE, Byer RL, Cadonati L, Cagnoli G, Camp JB, Cantley CA, Cardenas L, Carter K, Casey MM, Castiglione J, Chandler A, Chapsky J, Charlton P, Chatterji S, Chelkowski S, Chen Y, Chickarmane V, Chin D, Christensen N, Churches D, Cokelaer T, Colacino C, Coldwell R, Coles M, Cook D, Corbitt T, Coyne D, Creighton JDE, Creighton TD, Crooks DRM, Csatorday P, Cusack BJ, Cutler C, D'Ambrosio E, Danzmann K, Daw E, DeBra D, Delker T, Dergachev V, DeSalvo R, Dhurandhar S, Di Credico A, Díaz M, Ding H, Drever RWP, Dupuis RJ, Edlund JA, Ehrens P, Elliffe EJ, Etzel T, Evans M, Evans T, Fairhurst S, Fallnich C, Farnham D, Fejer MM, Findley T, Fine M, Finn LS, Franzen KY, Freise A, Frey R, Fritschel P, Frolov VV, Fyffe M, Ganezer KS, Garofoli J, Giaime JA, Gillespie A, Goda K, González G, Gossler S, Grandclément P, Grant A, Gray C, Gretarsson AM, Grimmett D, Grote H, Grunewald S, Guenther M, Gustafson E, Gustafson R, Hamilton WO, Hammond M, Hanson J, Hardham C, Harms J, Harry G, Hartunian A, Heefner J, Hefetz Y, Heinzel G, Heng IS, Hennessy M, Hepler N, Heptonstall A, Heurs M, Hewitson M, Hild S, Hindman N, Hoang P, Hough J, Hrynevych M, Hua W, Ito M, Itoh Y, Ivanov A, Jennrich O, Johnson B, Johnson WW, Johnston WR, Jones DI, Jones L, Jungwirth D, Kalogera V, Katsavounidis E, Kawabe K, Kawamura S, Kells W, Kern J, Khan A, Killbourn S, Killow CJ, Kim C, King C, King P, Klimenko S, Koranda S, Kötter K, Kovalik J, Kozak D, Krishnan B, Landry M, Langdale J, Lantz B, Lawrence R, Lazzarini A, Lei M, Leonor I, Libbrecht K, Libson A, Lindquist P, Liu S, Logan J, Lormand M, Lubinski M, Lück H, Lyons TT, Machenschalk B, MacInnis M, Mageswaran M, Mailand K, Majid W, Malec M, Mann F, Marin A, Márka S, Maros E, Mason J, Mason K, Matherny O, Matone L, Mavalvala N, McCarthy R, McClelland DE, McHugh M, McNabb JWC, Mendell G, Mercer RA, Meshkov S, Messaritaki E, Messenger C, Mitrofanov VP, Mitselmakher G, Mittleman R, Miyakawa O, Miyoki S, Mohanty S, Moreno G, Mossavi K, Mueller G, Mukherjee S, Murray P, Myers J, Nagano S, Nash T, Nayak R, Newton G, Nocera F, Noel JS, Nutzman P, Olson T, O'Reilly B, Ottaway DJ, Ottewill A, Ouimette D, Overmier H, Owen BJ, Pan Y, Papa MA, Parameshwaraiah V, Parameswariah C, Pedraza M, Penn S, Pitkin M, Plissi M, Prix R, Quetschke V, Raab F, Radkins H, Rahkola R, Rakhmanov M, Rao SR, Rawlins K, Ray-Majumder S, Re V, Redding D, Regehr MW, Regimbau T, Reid S, Reilly KT, Reithmaier K, Reitze DH, Richman S, Riesen R, Riles K, Rivera B, Rizzi A, Robertson DI, Robertson NA, Robison L, Roddy S, Rollins J, Romano JD, Romie J, Rong H, Rose D, Rotthoff E, Rowan S, Rüdiger A, Russell P, Ryan K, Salzman I, Sandberg V, Sanders GH, Sannibale V, Sathyaprakash B, Saulson PR, Savage R, Sazonov A, Schilling R, Schlaufman K, Schmidt V, Schnabel R, Schofield R, Schutz BF, Schwinberg P, Scott SM, Seader SE, Searle AC, Sears B, Seel S, Seifert F, Sengupta AS, Shapiro CA, Shawhan P, Shoemaker DH, Shu QZ, Sibley A, Siemens X, Sievers L, Sigg D, Sintes AM, Smith JR, Smith M, Smith MR, Sneddon PH, Spero R, Stapfer G, Steussy D, Strain KA, Strom D, Stuver A, Summerscales T, Sumner MC, Sutton PJ, Sylvestre J, Takamori A, Tanner DB, Tariq H, Taylor I, Taylor R, Taylor R, Thorne KA, Thorne KS, Tibbits M, Tilav S, Tinto M, Tokmakov KV, Torres C, Torrie C, Traylor G, Tyler W, Ugolini D, Ungarelli C, Vallisneri M, van Putten M, Vass S, Vecchio A, Veitch J, Vorvick C, Vyachanin SP, Wallace L, Walther H, Ward H, Ware B, Watts K, Webber D, Weidner A, Weiland U, Weinstein A, Weiss R, Welling H, Wen L, Wen S, Whelan JT, Whitcomb SE, Whiting BF, Wiley S, Wilkinson C, Willems PA, Williams PR, Williams R, Willke B, Wilson A, Winjum BJ, Winkler W, Wise S, Wiseman AG, Woan G, Wooley R, Worden J, Wu W, Yakushin I, Yamamoto H, Yoshida S, Zaleski KD, Zanolin M, Zawischa I, Zhang L, Zhu R, Zotov N, Zucker M, Zweizig J, Kramer M, Lyne AG. Limits on gravitational-wave emission from selected pulsars using LIGO data. Phys Rev Lett 2005; 94:181103. [PMID: 15904354 DOI: 10.1103/physrevlett.94.181103] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/29/2004] [Indexed: 05/02/2023]
Abstract
We place direct upper limits on the amplitude of gravitational waves from 28 isolated radio pulsars by a coherent multidetector analysis of the data collected during the second science run of the LIGO interferometric detectors. These are the first direct upper limits for 26 of the 28 pulsars. We use coordinated radio observations for the first time to build radio-guided phase templates for the expected gravitational-wave signals. The unprecedented sensitivity of the detectors allows us to set strain upper limits as low as a few times 10(-24). These strain limits translate into limits on the equatorial ellipticities of the pulsars, which are smaller than 10(-5) for the four closest pulsars.
Collapse
Affiliation(s)
- B Abbott
- LIGO-California Institute of Technology, Pasadena, CA 91125, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Siboni N, Fine M, Bresler V, Loya Y. Coastal coal pollution increases Cd concentrations in the predatory gastropod Hexaplex trunculus and is detrimental to its health. Mar Pollut Bull 2004; 49:111-118. [PMID: 15234880 DOI: 10.1016/j.marpolbul.2004.01.019] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 01/22/2004] [Indexed: 05/24/2023]
Abstract
Parameters of environmental health, including paracellular permeability of external epithelia, functional state of lysosomes and the level of metallothioneins (MTs), were examined using fluorescent markers and vital microfluorometry in different tissues of the marine gastropod, Hexaplex trunculus, from a coal-polluted and coal-free site. Vital microfluorometrical examinations exhibited enhanced paracellular permeability of external epithelia to the anionic marker, fluorescein (FLU), lower lysosomal accumulation of neutral red (NR) as well as higher levels of MTs, when compared with epithelia of gastropods from the coal-free site. Those differences were particularly marked in the foot epithelium, which is in direct contact with the substrate. In addition, cadmium was measured by ICP-AES in the hepatopancreas of gastropods sampled from the coal-polluted site and two coal-free sites. Significantly higher levels of Cd were found in gastropod hepatopancreas from the coal-polluted site. In addition, two months feeding experiments conducted in aquaria containing: (a) coal pieces covered by barnacles; (b) natural rocks covered by barnacles; and (c) natural rocks with barnacles + bare coal pieces, demonstrated significant increase of Cd concentration in the hepatopancreas of the gastropods exposed to coal. We suggest that coal in the marine environment has detrimental effects on marine gastropods, both directly through contact with the organisms and indirectly through the food web.
Collapse
Affiliation(s)
- N Siboni
- Department of Zoology, Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel
| | | | | | | |
Collapse
|
20
|
Chiu KC, Fine M, Ikle D, Slovak ML, Arber DA. Telomerase activity and proliferation index in aggressive mature B-cell lymphoma: comparison to germinal center phenotypic markers. Hum Pathol 2004; 34:1259-64. [PMID: 14691911 DOI: 10.1016/j.humpath.2003.07.009] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Cell proliferation may be evaluated by various methods, including Ki-67 immunohistochemistry and measures of telomerase activity. Both methods would theoretically show comparable increases in a given case. To evaluate the relationship between these 2 markers of proliferation in aggressive mature B-cell lymphomas, 48 cases were studied. The study group included 5 cases of mantle cell lymphoma (MCL); 6 cases of Burkitt's/Burkitt's-like lymphoma (BL); 9 cases of follicular lymphoma, grade 3 (FLC); and 28 cases of diffuse large B-cell lymphoma (DLC). Telomerase activity was measured as total product generated (TPG) units, and TPG results for the aforementioned cases were compared to the TPG results for 10 cases of reactive follicular hyperplasia. An overlap in TPG scores between reactive cases and lymphoma cases was found. Significant differences in both log TPG (P = 0.0443) and Ki-67 (P = 0.0006) were seen in the different lymphoma types. A positive correlation between Ki-67 percentage and TPG score was identified in FLC (r = 0.9281; P = 0.0003), but a poor correlation between these 2 indicators was seen in the other lymphoma types. Cluster analysis identified distinct patterns for MCL, FLC, and BL, but heterogeneous patterns for DLC. Because increases in both Ki-67 proliferation and telomerase activity are reported in normal germinal centers (GCs), these tests were also evaluated for usefulness as markers of a GC cell phenotype. Among the FLC and DLC cases, features of a GC phenotype significantly correlated with increased Ki-67 percentage (P = 0.0152), but not with increased log TPG. An elevated log TPG correlated with CD10 expression, and elevated Ki-67 percentage correlated with both CD10 and BCL-6 expression. TPG level and Ki-67 percentage did not correlate with the presence of t(14;18) or BCL-2 protein expression. Although the proliferation patterns were fairly distinctive for MCL, FLC, and BL, these studies show that markers of cell proliferation do not by themselves,identify distinct subtypes of large cell lymphomas. With the exception of FLC, the tumors exhibited poor correlation between telomerase activity and Ki-67 proliferation index. These tests did show some correlation with expression of GC cell phenotypic markers, however.
Collapse
Affiliation(s)
- Katharine C Chiu
- Division of Pathology, City of Hope National Medical Center, Duarte, CA, USA
| | | | | | | | | |
Collapse
|
21
|
Lederman G, Lowry J, Wertheim S, Fine M, Raden M, Silverman P, Volpicella F, Bockowski D, Lombardi E. Hearing preservation after hypofractionated radiosurgery for acoustic neuromas. Int J Radiat Oncol Biol Phys 2001. [DOI: 10.1016/s0360-3016(01)01904-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
22
|
Abstract
To evaluate the frequency and significance of myeloperoxidase positivity in adult acute lymphoblastic leukemia (ALL), bone marrow biopsy material from 82 adults with ALL was evaluated with a polyclonal myeloperoxidase (pMPO) antibody. Nineteen cases (23%) demonstrated evidence of pMPO immunoreactivity. Positive cases were precursor B-cell lineage, and CD13 or CD15 expression was more frequent than in the pMPO-negative cases. A subset of pMPO-positive cases studied with a monoclonal MPO antibody was negative. Western blot analysis using the pMPO antibody showed the expected 55-kd band for myeloperoxidase in pMPO-positive and pMPO-negative ALLs, suggesting a lack of specificity of this antibody in ALL. Forty-two percent (8/19) of the pMPO-positive ALL cases demonstrated evidence of t(9;22) by either karyotype or polymerase chain reaction analysis. The pMPO-positive ALLs had a lower frequency of extramedullary disease than the pMPO-negative group and a trend toward improved overall survival compared with the pMPO-negative group. Immunoreactivity with pMPO in adult ALL may lead to an incorrect interpretation of biphenotypic acute leukemia using a recently described scoring system, and a revision to that scoring system is proposed to accommodate pMPO-positive ALL.
Collapse
Affiliation(s)
- D A Arber
- Division of Pathology, City of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA 91010, USA
| | | | | | | | | | | |
Collapse
|
23
|
Fine M. The epidemiology of work and work-related disease in Rhode Island, 1876-2001. Med Health R I 2001; 84:189-91. [PMID: 11434146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/20/2023]
Abstract
Most Rhode Island workers now work in service industries, though many workers continue to be exposed to the risks of goods production in the workplace. Most reported occupational death is related to transportation and homicide, although in Rhode Island in 1999, exposure to harmful substances or environments was a significant cause of Rhode Island's few occupationally related deaths. How much occupational and environmental exposure contributes to Rhode Island's heart disease and cancer mortality rates in unknown. Musculoskeletal injuries are the predominant form of reported non-fatal occupational injuries, but there are questions about the completeness and accuracy of data on occupational injury and death.
Collapse
Affiliation(s)
- M Fine
- Department of Family and Community Medicine, Rhode Island Hospital.
| |
Collapse
|
24
|
Banin E, Israely T, Fine M, Loya Y, Rosenberg E. Role of endosymbiotic zooxanthellae and coral mucus in the adhesion of the coral-bleaching pathogen Vibrio shiloi to its host. FEMS Microbiol Lett 2001; 199:33-7. [PMID: 11356564 DOI: 10.1111/j.1574-6968.2001.tb10647.x] [Citation(s) in RCA: 79] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
Vibrio shiloi, the causative agent of bleaching the coral Oculina patagonica in the Mediterranean Sea, adheres to its coral host by a beta-D-galactopyranoside-containing receptor on the coral surface. The receptor is present in the coral mucus, since V. shiloi adhered avidly to mucus-coated ELISA plates. Adhesion was inhibited by methyl-beta-D-galactopyranoside. Removal of the mucus from O. patagonica resulted in a delay in adhesion of V. shiloi to the coral, corresponding to regeneration of the mucus. DCMU inhibited the recovery of adhesion of the bacteria to the mucus-depleted corals, indicating that active photosynthesis by the endosymbiotic zooxanthellae was necessary for the synthesis or secretion of the receptor. Further evidence of the role of the zooxanthellae in producing the receptor came from a study of adhesion of V. shiloi to different species of corals. The bacteria failed to adhere to bleached corals and white (azooxanthellate) O. patagonica cave corals, both of which lacked the algae. In addition, V. shiloi adhered to two Mediterranean corals (Madracis and Cladocora) that contained zooxanthellae and did not adhere to two azooxanthellate Mediterranean corals (Phyllangia and Polycyathus). V. shiloi demonstrated positive chemotaxis towards the mucus of O. patagonica. The data demonstrate that endosymbiotic zooxanthellae contribute to the production of coral mucus and that V. shiloi infects only mucus-containing, zooxanthellate corals.
Collapse
Affiliation(s)
- E Banin
- Department of Molecula Microbiology and Biotechnology, Tel Aviv university, Israel
| | | | | | | | | |
Collapse
|
25
|
Fine M. Governor Lucius F.C. Garvin, MD--Rhode Island's Champion Dreamer. Med Health R I 2001; 84:83-6. [PMID: 11280135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
Affiliation(s)
- M Fine
- Center for Occupational and Environmental Health of Rhode Island, USA.
| |
Collapse
|
26
|
Abstract
About 15% of metastatic breast carcinoma patients are diagnosed with brain metastases. Historically, the majority are treated with palliative external whole-brain radiation with a median survival of 4 months. We examined stereotactic radiosurgery's effect on treatment outcome in such patients. Four hundred and fifty four consecutive patients with brain metastases were treated with stereotactic radiosurgery at Staten Island University Hospital, NY, between 1991 and 1999. The medical records of 60 women with histologically confirmed breast cancer were retrospectively reviewed. Forty-three patients (71%) received fractionated radiosurgery (4 x 600 cGy) and form the core of this report. Sixty five percentage had been previously unsuccessfully treated by whole-brain radiation or had recurrence after craniotomy. Survival was calculated by the Kaplan-Meier method. The median age at diagnosis of brain metastases was 52 years, with median interval of 49 months following the diagnosis of tumor primary. Median survival from brain diagnosis reached 13.6 months. Overall median survival from radiosurgery treatment was 7.5 months. Fifteen patients with one or two brain lesions survived a median of 11.5 months. For the fractionated cohort of patients 1- and 2-year actuarial survival was 28.2% and 12.8%, respectively. Three patients are alive at 32, 34 and 64 months, respectively. We conclude that fractionated radiosurgery improves survival of patients with brain metastases from breast cancer, especially those with small lesions, good functional status and no other metastatic disease. These patients should be encouraged to consider radiosurgery, possibly before WBRT. Considering our 7.5 months overall survival including patients with multiple metastases, and patients with progressive brain metastases despite extensive standard therapy and often systemic disease, these results suggest that radiosurgery could benefit breast cancer patients with brain metastases and extend life.
Collapse
Affiliation(s)
- G Lederman
- Department Radiation Oncology, Staten Island University Hospital, New York, NY 10305, USA
| | | | | |
Collapse
|
27
|
Abstract
This paper takes up a theoretical and empirical investigation of how two community-based projects for young women both create safety from community and domestic violence but how, in the process, discourses of multicultural inclusion define one site, and racist discourses of exclusion float through the other site. By relying on two intensive qualitative case studies of community-based organizations for girls, one exclusively White and working class and the other expressly multicultural and antiracist, we try to identify those structures and practices that support feminist, but inadvertently racist, work and those structures and practices that enable, at once, feminist and antiracist consciousness and praxis.
Collapse
Affiliation(s)
- C Bertram
- Graduate Center, City University of New York, USA
| | | | | | | |
Collapse
|
28
|
Fine M. Family medicine, generalist medicine, specialist medicine and the conduct of the consultive relationship. Med Health R I 2000; 83:5-6. [PMID: 10695302] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/14/2023]
Affiliation(s)
- M Fine
- Center for Occupational and Environmental Health of Rhode Island.
| |
Collapse
|
29
|
Lederman G, Lowry J, Wertheim S, Fine M, Raden M, Silverman P, Volpicella F, Qian G, Pannullo S, Arbit E. Fractionated stereotactic radiosurgery (FSR) for acoustic neuroma (AN). Int J Radiat Oncol Biol Phys 2000. [DOI: 10.1016/s0360-3016(00)80306-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
30
|
Cataldo KA, Jalal SM, Law ME, Ansell SM, Inwards DJ, Fine M, Arber DA, Pulford KA, Strickler JG. Detection of t(2;5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue. Am J Surg Pathol 1999; 23:1386-92. [PMID: 10555007 DOI: 10.1097/00000478-199911000-00009] [Citation(s) in RCA: 99] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
Anaplastic large cell lymphoma (ALCL) is associated with the t(2;5)(p23;q35) translocation involving the anaplastic lymphoma kinase gene (ALK) and the nucleophosmin gene (NPM), which result in expression of a novel fusion protein, NPM-ALK (p80). Clinicopathologic studies have shown that ALK expression in ALCL is associated with improved 5-year survival rates when compared with ALCL lacking ALK expression. This study used paraffin-embedded tissue to compare interphase fluorescence in situ hybridization (FISH) and reverse transcriptase-polymerase chain reaction (RT-PCR) for the detection of t(2;5) with immunohistochemical analysis for the detection of ALK protein expression in 27 patients with CD30-positive ALCLs. ALK protein expression was detected with ALK1 antibody in 14 of the 27 patients. The neoplastic cells in 13 of these 14 lymphomas reacted with the p80NPM/ALK antibody. FISH, using a two-color ALK DNA probe, correlated 100% with the immunohistochemical results: a translocation involving the ALK gene was detected in all 14 lymphomas that reacted with anti-ALK1. RT-PCR, performed on 21 lymphomas, detected NPM-ALK mRNA in five of the lymphomas, all of which reacted with anti-ALK1 and showed ALK gene rearrangement by FISH. Lymphomas showing ALK1 reactivity occurred in a younger patient population (median age, 19.5 years) and were associated with improved 5-year survival rates (84%), as compared with lymphomas lacking ALK1 reactivity (median age, 68.0 years; 5-year survival rate, 35%; p = 0.008). We conclude that immunohistochemical studies, using antibody ALK1. and FISH for ALK gene rearrangement are equally effective for identifying patients with ALCL who have a favorable clinical outcome.
Collapse
Affiliation(s)
- K A Cataldo
- Department of Laboratory Medicine and Pathology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Fine M. All that wheezes isn't asthma: why primary care physicians don't use the guidelines for the diagnosis and treatment of asthma. Med Health R I 1999; 82:240. [PMID: 10439609] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/13/2023]
Affiliation(s)
- M Fine
- Rhode Island Academy of Family Practice, Center for Occupational and Environmental Health of Rhode Island, USA.
| |
Collapse
|
32
|
Lederman G, Lowry J, Wertheim S, Fine M, Raden M, Silverman P, Lombardi E, Qian G, Pannullo S, Arbit E. 1030 Fractionated Stereotactic Radiosurgery (FSR) for Acoustic Neuroma (AN). Int J Radiat Oncol Biol Phys 1999. [DOI: 10.1016/s0360-3016(99)90256-0] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
33
|
Ben-Atia I, Fine M, Tandler A, Funkenstein B, Maurice S, Cavari B, Gertler A. Preparation of recombinant gilthead seabream (Sparus aurata) growth hormone and its use for stimulation of larvae growth by oral administration. Gen Comp Endocrinol 1999; 113:155-64. [PMID: 9882554 DOI: 10.1006/gcen.1998.7192] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Gilthead seabream (Sparus aurata) growth hormone (gsGH) cDNA coding for the mature protein was cloned in a pGEM-T vector and then transferred into prokaryotic expression vector pET-8 and expressed in E. coli BL21 (DE3) cells upon induction with IPTG. The expressed protein, contained within the inclusion-body pellet, was solubilized in 4.5 M urea, refolded at pH 11.3 in the presence of catalytic amounts of cysteine, and purified to over 98% purity, as evidenced by SDS-PAGE. Gel-filtration on a Superdex column under nondenaturing conditions and partial amino acid N-terminal sequence showed the purified protein to be a monomeric alanyl-gsGH. Over 90% pure bacterial beta-lactamase was copurified as a by-product. Binding assays of the [125I]gsGH to gs liver microsomal fraction resulted in high specific binding characterized by a Kd = 1.93 nM. Recombinant gsGH, like ovine placental lactogen, exhibited growth-stimulating activity when applied orally to S. aurata larvae or intraperitoneally to juvenile fish.
Collapse
Affiliation(s)
- I Ben-Atia
- National Center for Mariculture, Israel Oceanographic and Limnological Research, Eilat, 88112, Israel
| | | | | | | | | | | | | |
Collapse
|
34
|
Fine M. The gates are opening for HMO members but the tolls are rising for hospitals. Manag Care Q 1998; 6:50-2. [PMID: 10177287] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/11/2023]
Affiliation(s)
- M Fine
- Max Fine Associates, Inc., Bethesda, MD, USA
| |
Collapse
|
35
|
Lederman G, Lowry J, Wertheim S, Fine M, Lombardi E, Wronski M, Arbit E. Acoustic neuroma: potential benefits of fractionated stereotactic radiosurgery. Stereotact Funct Neurosurg 1998; 69:175-82. [PMID: 9711752 DOI: 10.1159/000099871] [Citation(s) in RCA: 63] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
BACKGROUND Single-fraction radiosurgery of acoustic neuromas less than 3 cm in diameter is remarkable for high control but not infrequent incidence of facial and trigeminal neuropathy. Larger tumors treated surgically often result in deafness and facial neuropathy. Fractionated stereotactic radiosurgery was used in an effort to maintain effective therapy while minimizing toxicity of treatment. METHODS The authors described 38 patients with acoustic neuromas, with age range 35-89 years (mean, 60 years). 2,000 cGy in divided weekly doses of 400 or 500 cGy was most commonly prescribed. Tumors > or = 3 cm (n = 16) received the 5 fraction schema. Mean tumor volume was 6.9 cm3, with range from 0.1 to 32.0 cm3. RESULTS Median clinical follow-up was 27.1 months, while neuroimaging follow-up had a median of 16.3 months. All tumors were controlled. Of 23 tumors smaller than 3 cm, 14 (61%) decreased in size, and 9 showed cessation of growth. Thirteen of 16 (81%) large acoustic neuromas (3-5 cm) diminished in size. The remaining 3 showed cessation of growth. Median radiographic follow-up was 20 months, with a median clinical follow-up of 28 months. No patient developed fifth nerve symptoms after treatment nor did any patient require surgery for treatment failure. Only one had temporary seventh nerve palsy. CONCLUSION Fractionated stereotactic radiosurgery offers a therapeutic approach producing high control rates while avoiding morbidity frequently seen after single-fraction radiosurgery or microsurgery.
Collapse
Affiliation(s)
- G Lederman
- Department of Radiation Oncology, Staten Island University Hospital, N.Y., USA
| | | | | | | | | | | | | |
Collapse
|
36
|
Fine M, Stein B, Lindenmayer JM. Proposed prostate cancer screening recommendation--clarified. Med Health R I 1998; 81:243-4. [PMID: 9689791] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Affiliation(s)
- M Fine
- Department of Urology, Rhode Island Hospital, USA
| | | | | |
Collapse
|
37
|
Fine M, Tobias AH. ECG of the month. Sinus arrhythmia in pinnipeds. J Am Vet Med Assoc 1998; 212:351-3. [PMID: 9470040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Affiliation(s)
- M Fine
- College of Veterinary Medicine, Oregon State University, Corvallis 97331, USA
| | | |
Collapse
|
38
|
Rashid H, Lowry J, Wertheim S, Fine M, Silverman P, Lombardi E, Qian G, Arbit E, Lederman G. Improved results for acoustic neuroma (An) treated with fractionated stereotactic radiosurgery (FSR). Int J Radiat Oncol Biol Phys 1998. [DOI: 10.1016/s0360-3016(98)80275-7] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
39
|
Fine M, Mirmirani S. Can communities afford population-based primary health care? MEDICINE AND HEALTH, RHODE ISLAND 1998; 81:26-8. [PMID: 9473939] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Affiliation(s)
- M Fine
- Hillside Avenue Family and Community Medicine, Rhode Island, USA
| | | |
Collapse
|
40
|
Lederman G, Odaimi M, Fine M, Wertheim S, Lowry J, Wrzolek M, Rashid H, Quan G, Lombardi E, Arbit E. Treatment of recurrent glioblastoma multiforme (RGM): Fractionated stereotactic radiosurgery (FSR) and concurrent taxol (T). Int J Radiat Oncol Biol Phys 1998. [DOI: 10.1016/s0360-3016(98)80389-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
41
|
Evans AA, Fine M, London WT. Spontaneous seroconversion in hepatitis B e antigen-positive chronic hepatitis B: implications for interferon therapy. J Infect Dis 1997; 176:845-50. [PMID: 9333140 DOI: 10.1086/516538] [Citation(s) in RCA: 54] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
This study compared rates of spontaneous hepatitis B e antigen (HBeAg)-positive to -negative seroconversion in chronic carriers of hepatitis B virus (HBV) with rates reported during interferon-alpha therapy. Four hundred fifty-four Asian-American HBeAg-positive HBV carriers, followed for 1-10 years, were tested approximately every 6 months for HBeAg. Patients with alanine aminotransferase levels > or = 50 IU/mL at entry had 1067.3 seroconversions/10(5) person-months in the 5- to 19-year age group, 1753.3 in the 20- to 34-year group, and 1257.2 in the 35- to 50-year group. Published data indicate that 30% of children and 33% of adults seroconvert during interferon-alpha treatment and follow-up. In our study population, spontaneous seroconversion occurred in 15% of children (95% confidence interval [CI], 8%-27%), 23% of adults 20-34 years (95% CI, 15%-34%), and 17% of adults 35-50 years (95% CI, 10%-28%) during the same interval. The high rate of spontaneous seroconversion should be weighed in decisions to treat HBV carriers with interferon-alpha.
Collapse
Affiliation(s)
- A A Evans
- Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
| | | | | |
Collapse
|
42
|
Lederman G, Odaimi M, Fine M, Wertheim S, Lowry J, Wrzolek M, Rashid H, Qian G, Lombardi E, Arbit E. Improved survival using fractionated stereotactic radiosurgery (FSR) and concurrent taxol (T) for recurrent glioblastoma multiforme (RGM). Eur J Cancer 1997. [DOI: 10.1016/s0959-8049(97)85628-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
43
|
Lederman G, Lowry J, Wertheim S, Fine M, Voutsinas L, Silverman P, Lombardi E, Qian G, Rachid H, Arbit E. Acoustic neuromas (AN) treated by fractionated stereotactic radiosurgery (FSR). Eur J Cancer 1997. [DOI: 10.1016/s0959-8049(97)86061-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
44
|
|
45
|
Fine M, Amuly R, Sandowski Y, Marchant TA, Chan SJ, Gertler A, Funkenstein B. Recombinant gilthead seabream (Sparus aurata) insulin-like growth factor-I: subcloning, expression in Escherichia coli, purification and characterization. J Endocrinol 1997; 153:139-50. [PMID: 9135579 DOI: 10.1677/joe.0.1530139] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Gilthead seabream (Sparus aurata) insulin-like growth factor-I (gsIGF-I) cDNA coding for the mature protein was cloned in a pGEM-3Z vector, and then transferred into prokaryotic expression vector pET-11a and expressed in Escherichia coli BL21(DE3) cells upon induction with isopropyl thiogalactoside. The expressed protein contained within the inclusion-body pellet was solubilized in 4.5 M urea, refolded for 24 h at pH 11.3 in the presence of catalytic amounts of cysteine and purified to over 98% purity, as a monomeric methionyl-gsIGF-I. Amino acid composition and N-terminal sequence confirmed the identity to be the predicted protein. Binding assays of the 125I-gsIGF-I to gilthead seabream or carp (Cyprinus carpio) sera resulted in high specific binding, indicating the existence of one or more IGF-binding proteins. In binding experiments to crude gilthead seabream brain homogenate, using human (h) IGF-I as a ligand, the respective IC50 value of hIGF-I was about fourfold lower than that of gsIGF-I. Recombinant gsIGF-I exhibited mitogenic activity in a mouse mammary gland-derived MME-L1 cell line which was approximately 200-fold lower than that of hIGF-1. Binding experiments to intact MME-L1 cells suggests that this difference most likely results from a correspondingly lower affinity for IGF-I receptor in these cells. In contrast, the activities of gsIGF-I and hIGF-I measured by 35S uptake by gill arches from the goldfish (Carassius auratus) were identical, indicating that the recombinant gsIGF-I is biologically active.
Collapse
Affiliation(s)
- M Fine
- Institute of Biochemistry, Food Science and Nutrition, Faculty of Agriculture, Hebrew University of Jerusalem, Rehovot, Israel
| | | | | | | | | | | | | |
Collapse
|
46
|
Qian G, Lowry J, Wertheim S, Fine M, Voutsinas L, Silverman P, Lombardi E, Rashid H, Arbit E, Lederman G. 1019 Control of acoustic neuroma (AN) by fractionated stereotactic radiation (FSR). Int J Radiat Oncol Biol Phys 1997. [DOI: 10.1016/s0360-3016(97)80739-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
47
|
|
48
|
Lederman G, Odaimi M, Albert S, Wertheim S, Lowry J, Fine M, Silverman P, Klein E. 268 Fractionated stereotactic radiosurgery (FSR) and concurrent taxol for recurrent high grade brain tumors (RBT). Eur J Cancer 1995. [DOI: 10.1016/0959-8049(95)95526-c] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
49
|
Horowitz SW, Leonetti JP, Azar-Kia B, Fine M, Izquierdo R. CT and MR of temporal bone malignancies primary and secondary to parotid carcinoma. AJNR Am J Neuroradiol 1994; 15:755-62. [PMID: 8010279 PMCID: PMC8334200] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
PURPOSE To review the CT and MR characteristics of temporal bone malignancy, and to evaluate the relationship between malignancies of the temporal bone and parotid gland. METHODS A group of 15 surgical patients with diagnosis of temporal bone malignancy were retrospectively reviewed. These included 11 cases of primary temporal bone malignancy and four cases of secondary carcinoma of the temporal bone from a primary tumor of the parotid gland. Three primary temporal bone malignancies were recurrences, and two secondary tumors were parotid recurrences. RESULTS Five of the 11 patients with primary temporal bone malignancy had parotid infiltration (45%). All four patients with secondary temporal bone destruction caused by parotid carcinoma had erosion of the mastoid, two with erosion of the external auditory canal, and one of the middle ear. CONCLUSIONS It is important radiographically to recognize the close relationship between malignancies of the temporal bone and parotid gland, because either may secondarily invade the other. Suspicion of malignancy in either the temporal bone or parotid gland necessitates complete imaging of the other structure. Temporal bone or skull base erosion were best seen on CT at bone algorithm. MR with and without infusion provided excellent delineation of soft-tissue tumor margins, muscle infiltration, intracranial extension, and vascular encasement.
Collapse
Affiliation(s)
- S W Horowitz
- Department of Radiology, Loyola University Medical Center, Maywood, IL 60153
| | | | | | | | | |
Collapse
|
50
|
Derlon JM, Petit-taboué MC, Dauphin F, Courtheoux P, Chapon F, Creissard P, Darcel F, Houtteville JP, Kaschten B, Sadzot B, Stevenaert A, Tjuvajev JG, Macapinlac HA, Daghighian F, Ginos JZ, Finn RD, Jiaju Zhang MS, Beattie B, Graham M, Larson SM, Blasberg RG, Levivier M, Goldman S, Pirotte B, Brucher JM, Balériaux D, Luxen A, Hildebrand J, Brotchi J, Go KG, Kamman RL, Mooyaart EL, Heesters MAAM, Sijens PE, Oudksrk M, van Dijk P, Levendag PC, Vecht CJ, Metz RJ, Kennedy DN, Rosen BR, Hochberg FH, Fishman AJ, Filipek PA, Caviness VS, Gross MW, Weinzierl FX, Trappe AE, Goebel WE, Frank AM, Becker G, Krone A, Schmidt K, Hofmann E, Bogdahn U, Bencsch H, Fclber S, Finkenstedt G, Kremser C, Sfockhammer G, Aichner F, Bogdahn U, Fröhlich T, Becker G, Krone A, Schlief R, Schürmann J, Jachimczak P, Hofmann E, Roggendorf W, Roosen K, Carapella CM, Carpinelli G, Passalacqua R, Raus L, Giannini M, Mastrostefano R, Podo F, Tofani A, Maslrostefano R, Mottoles M, Ferraironi A, Scelsa MG, Oppido P, Riccio A, Maini CL, Collombier L, Taillandier L, Dcbouverie M, Laurens MH, Thouvenot P, Weber M, Bertrand A, Cruickshank GS, Patterson J, Hadley D, De Witte O, Hildebrand J, Luxen A, Goldman S, Reifenberger J, Liu L, James CD, Wechsler W, Collins VP, Fabel-Schulte K, Jachimczak P, Heßdörfer B, Baur I, Schlingensiepen KH, Ernestus RI, Brysch W, Bogdahn U, Blesch A, Bosserhoff AK, Apfel R, Lottspeich F, Jachimczak P, Büttner R, Bogdahn U, Cece R, Bockhorst K, Barajon I, Tazzari S, Cavaletti G, Torri-Tarelli L, Tredici G, Hecht B, Turc-Carel C, Atllas R, Chatel M, Gaudray P, Eis M, Gioanni J, Hecht F, Balledux J, Rothbart D, Criscuolo GR, de Campos JM, Kusak ME, Rey JA, Bello MJ, Sarasa JL, Els T, Dubois F, Blond S, Parent M, Assaker R, Gosselin P, Christiaens JL, Feld R, Moringlane JR, Steudel WI, Schaudies JR, Hoehn-Berlage M, Janka M, Tonn JC, Fischer U, Meese E, Roosen K, Remmelink M, Salmon I, Cras P, Pasteels JL, Brotchi J, Gliese M, Kiss R, Bensadoun RJ, Frenay M, Formento JL, Milano G, Lagrange JL, Grellier P, Lee JY, Ernestus RI, Riese HH, Fründ R, Cervós-Navarro J, Reutter W, Lippitz B, Scheitinger C, Scholz M, Weis J, Gilsbach JM, Füzesi L, Koochekpour S, Merzak A, Geissler A, Pilkington GJ, Sanson M, Li YJ, Hoang-Xuan K, Delattre JY, Poisson M, Hamelin R, Van de Kelft E, Dams E, Martin JJ, Woertgen C, Willems P, Lehrke R, Voges J, Treuer H, Erdmann J, Müller RP, Sturm V, Wurm RE, Warrington AP, Laing RW, Holzschuh M, Sardell S, Hines F, Graham JD, Brada M, Ushio Y, Kuratsu JI, Kochi M, Kitz K, Aichholzer M, Rössler K, Goldman S, Alesch F, Ertl A, Sorensen PS, Helweg-Larsen S, Mourldsen H, Hansen HH, El Sharoum SY, Berfelo MW, Theunissen PHMH, Jager JJ, Levivier M, de Jong JMA, Fedorcsák I, Nyáry I, Osztie É, Horvath Á, Kontra G, Frenay M, Burgoni-chuzel J, Paquis P, Lagrange JL, Pirotte B, Helweg-Larsen S, Hansen SW, Sørensen PS, Salmon I, Kiss R, Krauseneck P, Müller B, Morche M, Tonn JC, Lagerwaard FJ, Brucher JM, Levendag PC, Eijkenboom WMH, Schmilz PIM, Lentzsch S, Weber F, Franke J, Dörken B, Lunardi P, Schettini G, Osman FJ, Luxen A, Qasho R, Mocellini C, Ruda R, Soffietti R, Garabello D, Sales S, De Lucchi R, Vasario E, Schiffer D, Muracciole X, Brotchi J, Régis J, Manera L, Peragut JC, Juin P, Sedan R, Nieder C, Niewald M, Walter K, Schnabel K, Nieder C, Hildebrand J, Niewald N, Nestle U, Schnabel K, Berberich W, Oschmann P, Theißen RD, Reuner KH, Kaps M, Dorndorf W, Martin KK, Hausmann O, Akinwunmi J, Rooprai HK, Kennedy A, Linke A, Ognjenovic N, Pilkington GJ, Svadovsky AI, Peresedov VV, Bulakov AA, Butyalko MY, Merlo A, Zhirnova IG, Labunsky DA, Gnazdizky VV, Gannushkina IV, Taphoorn MJB, Potman R, Barkhof F, Weerts JG, Karim ABMF, Heimans JJ, Jerrnann E, van de Pol M, van Aalst VC, Wilmink JT, Twijnstra A, van der Sande JJ, Boogerd W, Kröger R, Jäger A, Wismeth C, Dekant A, Uirich J, Brysch W, Schlingensiepen KH, Jachimczak P, Bogdahn U, Pirolte B, Cool V, Gérard C, Levivier M, Dargent JL, Goldman S, Chiquet-Ehrismann R, Brotchi J, Hildebrand J, Velu T, Herrlinger U, Schabet M, Ohneseit P, Buchholz R, Zhu J, Reszka R, Weber F, Müller J, Walther W, Zhang LI, Brock M, Roosen N, Rock JP, Zeng H, Feng J, Fenstermacher JD, Rosenblum ML, Siegal T, Mäcke H, Gabizon A, Beljanski M, Crochet S, Bergenheim AT, Zackrisson B, Elfverson J, Bergström P, Henriksson R, Butti G, Baetta R, Gratzl O, Magrassi L, De Renzis MR, Soma MR, Davegna C, Pezzotta S, Paoletti R, Fumagalli R, Infuso L, Sankar AA, Darling JL, Herholz K, Thomas DGT, Defer GL, Brugières P, Gray F, Chomienne C, Poirier J, Degos L, Degos JD, Colombo BM, DiDonato S, Ghaemi M, Finocchiaro G, Hebeda KM, Sterenborg HJCM, Saarnak AE, Wolbers JG, van Gemert MJC, Kaaijk P, Troost D, Leenstra S, Das PK, Würker M, Bosch DA, Kostron H, Hochleitner BW, Obwegeser A, Ortler M, Seiwald M, Vooys W, Krouwer HGJ, de Gast GC, Marx JJM, Pietrzyk U, Osman FJ, Lunardi P, Puzzilli F, Menovsky T, Beek JF, Wolbers JG, van Gemert MJC, Naujocks G, Wiestler OD, Schirrmacher V, Heiss WD, Schramm J, Schmitz A, Eis-Hübinger AM, Piepmeier PH, Pedersen P, Greer C, Quigley MR, Shih T, Elrifal A, Rothfus W, Kotitschke K, Maroon JC, Rohertson L, Rampling R, Whoteley TL, Piumb JA, Kerr DJ, Falina PA, Crossan IM, Roosen N, Rock JP, Brandl M, Feng J, Zeng H, Ho KL, Fenstermacher JD, Rosenblum ML, Ruchoux MM, Vincent S, Jonca F, Plouet J, Lecomte M, Tonn JC, Samid D, Thibault A, Ram Z, Oldfield EH, Myers CE, Reed E, Schabet M, Herrlinger U, Buchholz R, Shoshan Y, Haase A, Siegal T, Siegal T, Shezen E, Siegal T, Stockhammer G, Rosenblum M, Samid D, Lieberman F, Terzis AJA, Bjerkvig R, Bogdahn U, Laerum OD, Arnold H, Thibault A, Samid D, Figg WD, Myers CE, Reed E, Thomas R, Flux G, Chittenden S, Kotitschke K, Doshi P, Brazil L, Thomas DGT, Bignor D, Zalutsky M, Brada M, Tjuvajev J, Kaplitt M, Desai R, Bradley MS, Muigg S, Bettie BS, Gansbacher B, Blasberg R, Haugland HK, Saraste J, Rooseni K, Laerum OD, Vincent AJPE, Avezaat CJJ, Bout A, Felber S, Noteboom JL, Vecht CH, Valerio D, Hoogerbrugge PM, Weber F, Reszka R, Zhu J, Walther W, List J, Schulz W, Aichner F, Wolbers JG, Sterenborg IIJCM, Kamphorst W, van Gemert MJC, van Alplien HAM, Salander P, Bergenheim T, Henriksson R, Grant R, Brazil L, Haase A, Thomas R, Guerrero D, Laing R, Ashley S, Brada M, Schmidt B, Bauer B, Grau G, Bohnstedt T, Frydrych A, Bogdahn U, Franz K, Lorenz R, Brandes A, Amanzo PD, Zampieri P, Rigon A, Scelzi E, Rotilio A, Berti F, Paccagnella A, Krone A, Fiorentino MV, Müller B, Krauseneck P, van Deventer PL, Dellemijn PLI, van den Bent MJ, Vecht CJ, Kansen PJ, Tredici G, Petruccioli NG, Becker G, Cavaletti G, Cavalletti E, Kiburg B, Müller LJ, Moorer-van Delft CM, Heimans JJ, Boer HH, Pace A, Bove L, Pietrangeli A, Woydt M, Innocenti P, Aloe A, Nardi M, Jandolo B, Kellie SJ, De Graaf SSN, Bloemhof H, Roebuck D, Dalla PL, Uges DDR, Roggendorf W, Johnston I, Besser M, Chaseling RA, Koeppen S, Gründemann S, Lossos A, Siegal T, Nitschke M, Vieregge P, Reusche E, Hofmann E, Rob P, Kömpf D, Postma TJ, Vermorken JB, Heimans JJ, Rampling RP, Dunlop DJ, Steward MS, Campbell SM, Roy S, Bogdahn U, Hilkens PHE, Verweij J, van Putten WLJ, Vecht CJ, van den Bent MJ, Hilkens PHE, Moll JWB, van der Burg MEL, Planting AST, van Putten WLJ, Roosen K, Vecht CJ, van den Bent MJ, Wondrusch E, Zifko U, Drlicek M, Liszka U, Grisold W, Zifko U, Fazeny B, Dittrich C, Lanfermann H, Wondrusch E, Grisold W, Verschuuren JJ, Meneses PI, Rosenfeld MR, Kaplitt MG, Posner JB, Dalmau J, Sillevis Smitt PAE, Manley G, Heindel W, Posner JB, Cavaletti G, Bogliun G, Margorati L, Bianchi G, Drlicek M, Liska U, Casati B, Kolig C, Grisold H, Kugel H, Graus F, Reñe R, Uchuya M, Valldeoriola F, Delattre JY, Benedetti de Cosentiro C, Ortale D, Martinez R, Lambre J, Cagnolati S, Erneslus RI, Vinai C, Salmaggi A, Nemni R, Silvani A, Forno MG, Luksch R, Confalonieri P, Boiardi A, Nitschke M, Scholz J, Röhn G, Vieregge P, Kömpf D, Hochberg FH, Pfeiffer G, Netzer J, Hansen C, Eggers C, Hagel C, Kunze K, Verschuuren JJ, Lackner K, Rosenblum MK, Lieberman FS, Posner JB, Dalmau J, Metz RJ, Kennedy DN, Pardo FS, Kutke S, Sorensen AG, Hochberg FH, Fishman AJ, Filipek PA, Rosen BR, Caviness VS, Mechtler LL, Withiam-Lench S, Shin K, Klnkel WR, Patel M, Truax B, Kinkel P, Shin K, Mechtler L, Ricci M, Pantano P, Maleci A, Pierallini S, Di Stefano D, Bozzao L, Cantore GP, Röhn G, Els T, Schröder R, Hoehn-Berlage M, Ernestus RI, Ruda R, Mocellini C, Soffietti R, Campana M, Ropolo R, Riva A, de Filippi PG, Schiffer D, Salgado D, Rodrigues M, Salgado L, Fonseca AT, Vieira MR, Bravo Marques JM, Satoh H, Uozumi T, Kiya K, Kurisu K, Arita K, Sumida M, Ikawa F, Tzuk-Shina T, Gomori JM, Rubinstein R, Lossos A, Siegal T, Vaalburg W, Paans AMJ, Willemsen ATM, van Waarde A, Pruim J, Visser GM, Go KG, Valentini S, Ting YLT, De Rose R, Chidichimo G, Corricro G, van Lcycn-Pilgram K, Erncslus RI, Klug N, van Leyen-Pilgram K, Ernestus RI, Schröder R, Klug N, Woydt M, Krone A, Tonn JC, Becker G, Neumann U, Roggendorf W, Roosen K, Plate KH, Breier G, Millaucr B, Weich HA, Ullrich A, Risau W, Roosen N, Chopra RK, Mikkelsen T, Rosenblum SD, Yan PS, Knight R, Windham J, Rosenblum ML, Schiffer D, Attanasio A, Cavalla P, Chio A, Giordana MT, Migheli A, Amberger V, Hensel T, Schwab ME, Cervoni L, Celli P, Tarantino R, Huettner C, Tonn JC, Berweiler U, Roggendorf W, Salmon I, Rorive S, Rombaut K, Pirotte B, Haot J, Brotchi J, Kiss R, Maugard-Louboutin C, Charrier J, Fayet G, Sagan C, Cuillioere P, Ricolleau G, Martin S, Menegalli-Bogeelli D, Lajat Y, Resche F, Molnàr P, Bárdos H, Ádány R, Rogers JP, Pilkington GJ, Pollo B, Giaccone G, Allegranza A, Bugiani O, Prim J, Badia J, Ribas E, Coello F, Shezen E, Lossos A, Abramsky O, Siegal T, Scerrati M, Roselli R, Iacoangeli M, Pompucci A, Rossi GF, Deeb SMA, Koreich O, Yaqub B, Moutaery KRA, Giordana MT, Cavalla P, Chio A, Marino S, Vigliani MC, Schiffer D, Deburghgraeve V, Darcel F, Gedouin D, Hassel MB, Guegan Y, Jeremic B, Grujicic D, Antunovic V, Matovic M, Shibamoto Y, Kallio M, Huhmar H, Kudoh C, Detta A, Sugiura K, Hitchcock ER, Mastrostefano R, Di Russo R, Cipriani§ M, Occhipinti EM, Conti EMS, Clowegeser A, Ortler M, Seiwald M, Kostron H, Rajan B, Ross G, Lim C, Ashlcy S, Goode D, Traish D, Brada M, Sanden GACV, Schouten LJ, Coebergh JWW, Razenberg PPA, Twijnstra A, Snilders-Keilholz A, Voormolen JHC, Hermans J, Leer JWH, Taillandier L, Baylac F, Dcbouvcrie M, Anxionnal R, Bracard S, Vignand JM, Duprcz A, Weber M, Winking M, Böker DK, Simmet T, Rothbart D, Strugar J, Balledux J, Criscuolo GR, Jachimczak P, Blesch A, Heβdörfer B, Bogdahn U, Ernestus RI, Schröder R, Klug N, Krouwer HGJ, Duinen SGV, Algra A, Zentner J, Wolf HK, Ostertun B, Hufnagel A, Campos MG, Solymosi L, Schramm J, Newlands ES, O'Reilly SM, Brampton M, Soffietti R, Chio A, Mocellini C, Ruda R, Vigliani MC, Schiffer D, Sciolla R, Seliak D, Henriksson R, Bergenheim AT, Björk P, Gunnarsson PO, Hariz M, Grant R, Collie D, Gregor A, Ebmeier KP, Jarvis G, Lander F, Cull A, Sellar R, Brada M, Thomas C, Elyan S, Hines F, Ashley S, Stenning S, Bernstein JJ, Goldberg WJ, Roelcke U, Von Ammon K, Hausmann O, Radu EW, Kaech D, Leenders KL, Fitzek MM, Aronen JE, Hochberg F, Gruber M, Schmidt E, Rosen B, Flschman A, Pardo P, Afra UMU, Sipos L, Slouik F, Boiardi A, Salmaggi A, Pozzi A, Farinotti L, Fariselli L, Silvani A, Brandes A, Scelzi E, Rigon A, Zampieri P, Pignataro M, Amanzo PD, Amista P, Rotilio A, Fiorentino MV, Thomas R, Brazil L, O'Connor AM, Ashley S, Brada M, Salvati M, Cervoni L, Puzzilli F, Cervoni L, Salvati M, Raguso M, Cruickshank GS, Duckworth R, Rumpling R, Rottuci M, Fariselli L, Boiardi A, Broggi G, Plrint NG, Sabattini E, Manetto V, Gambacorta H, Poggi S, Pileri S, Ferracini R, Grant R, Plev DV, Hopf NJ, Knosp E, Bohl J, Perncczky A, Kiss R, Salmon I, Catnby I, Dewitte O, Brotchi J, Pasteels JL, Camby I, Salmon I, Darro F, Danguy A, Brotchi J, Pasteels JL, Kiss R, Kiu MC, Lai GM, Yang TS, Ng KT, Chen JS, Chang CN, Leung WM, Ho YS, Rychter MD, Klimek A, Liberski PP, Karpinaka A, Krauseneck P, Schöffel V, Müller B, Kreth FW, Faist M, Warnke PC, Ostertag CB, Nielen KMBV, Visscr MC, Lebrun C, Lonjon M, Desjardin T, Michiels JF, Chanalet SLJL, Roche JL, Chatel M, Mastronardi L, Puzzilli F, Osman FJ, Lunardi P, Matsutani M, Ushio Y, Takakura K, Menten J, Hamers H, Ribot J, Dom R, Tcepen H, Müller B, Weidner N, Krauseneck P, Naujocks G, van Roost D, Wiestler OD, Kuncz A, Nieder C, Setzel-Sesterhein M, Niewald M, Schnabel I, O'Neill KS, Kitchen ND, Wilkins PR, Marsh HT, Pierce E, Doshi R, Deane R, Previtali S, Quattrini A, Nemni R, Ducati A, Wrabetz L, Canal N, Punt CJA, Stamatakis L, Giroux B, Rutten E, Quigley MR, Beth Sargent PAC, Flores N, Simon S, Maroon JC, Quigley MR, Beth Sargent PAC, Flores N, Maroon JC, Rocca AA, Gervasoni C, Castagna A, Picozzi P, Giugni E, Rocca AA, Tonnarelli GP, Ducati A, Mangili F, Truci G, Canal N, Giovanelli M, Roelcke U, Von Ammon K, Radu EW, Leenders KL, Sachsenheimer W, Bimmler T, Seiwald M, Eiter HRW, Ortler M, Obwegesser A, Kostron H, Steilen H, Henn W, Moringlane JR, Kolles H, Feiden W, Zang KD, Sleudel WI, Steinbrecher A, Schabet M, Heb C, Bamberg M, Dichgans J, Stragliotto G, Delattre JY, Poisson M, Zampieri P, Brandes A, Rigon A, Tosatto L, D'Amanzo P, Menicucci N, Rotilio A, Mingrino S, Steudel WI, Feld R, Henn W, Zang KD, Maire JP, Caudry M, Guerin J, Celerier D, Salem N, Demeaux H, Fahregat JF, Kusak ME, Bucno A, Albisua J, Jerez P, Sarasa JL, Garefa R, de Campos JM, Kusak ME, de Campos JM, Bueno A, García-Delgado R, Sarasa JL, García-Sola R, Lantsov AA, Shustova TI, Lcnartz D, Wellenreuther R, von Deirnling A, Köning W, Menzel J, Scarpa S, Manna A, Reale MG, Oppido PA, Carapella CM, Frati L, Valery CA, Ichen M, Foncin JP, Soubrane C, Khayat D, Philippon J, Vaz R, Cruz C, Weis S, Protopapa D, März R, Winkler PA, Reulen HJ, Bise K, Beuls E, Berg J, Deinsberger W, Böker DK, Samii M, Caudry M, Darrouzet V, Guérin J, Trouette R, Causse N, Bébéar JP, Parker F, Vallee JN, Carlier R, Zerah M, Lacroix-Jousselin C, Piepmeier JM, Kveton J, Czibulka A, Tigliev GS, Chernov MP, Maslova LN, Valdueza JM, Jänisch W, Bock A, Harms L, Bessell EM, Graus F, Punt J, Firth J, Hope T, Koriech O, Al Deeb S, Al Moutaery K, Yaqub B, Silvani A, Salmaggi A, Pozzi A, Franzini A, Boiardi A, Goldbrunner R, Warmuth-Metz M, Paulus W, Tonn JC, Roosen K, Strik II, Müller B, Markert C, Pflughaupt KW, Krauseneck P, O'Neill BP, Dinapoli RP, Voges J, Sturm V, Deuß U, Traud C, Treuer H, Lehrke R, Kim DG, Müller RP, Alexandrov YS, Moutaery K, Aabed M, Koreich O, Ross GM, Rajan B, Traish D, Ashley S, Ford D, Brada M, Schmeets ILO, Jager JJ, Pannebakker MAG, de Jong JMA, van Lindert E, Knosp E, Kitz K, Blond S, Dubois F, Assaker R, Baranzelli MC, Sleiman M, Pruvo JP, Coche-Dequeant B, Matsutani M, Takakura K, Sano K, PetriČ-Grabnar G, Jereb B, Župančič N, Koršič M, Rainov NG, Burkert W, Ushio Y, Kochi M, Itoyama Y, de Campos JM, Kusak ME, Sarasa JL, García R, Bueno A, Ferrando L, Hoang-Xuan K, Sanson M, Merel P, Delattre JY, Poisson M, Delattre O, Thomas G, Hoang-Xuan K, Delattre JY, Poisson M, Thomas G, Haritz D, Obersen B, Grochulla F, Gabel D, Haselsberger K, Radner H, Pendl G, Brada M, Laing RW, Warrington AP, Nowak PJCM, Kolkman-Deurloo IKK, Visser AG, Berge HD, Niël CGJH, Levendag PC, Bergström P, Hariz M, Löfroth PO, Bergenheim T, Henriksson R, Blond S, Assaker R, Cortet-rudelli C, Dewailly D, Coche-dequeant B, Castelain B, Dinapoli R, Shaw E, Coffey R, Earle J, Foote R, Schomberg P, Gorman D, Girard N, Courel MN, Delpech B, Haselsberger K, Friehs GM, Schröttner O, Pendl G, Pötter R, hawliczek R, Sperveslage P, Prott FJ, Wachter S, Dieckmann K, Würker M, Herholz K, Pietrzyk U, Voges J, Treuer H, Sturm V, Bauer B, Heiss WD, Jund R, Zimmermann F, Feldmann HJ, Gross MW, Kneschaurek P, Molls M, Lederman G, Lowry J, Wertheim S, Voulsinas L, Fine M, Lederman G, Lowry J, Wertheim S, Fine M, Voutsinas I, Qian G, Rashid H, Lederman G, Lowry J, Wertheim S, Fine M, Voulsinas L, Qian G, Rashid H, Moutaery K, Aabed M, Koreich O, Scerrati M, Montemaggi P, Iacoangeli M, Pompucci A, Roselli R, Trignani R, Rossi GF, Shin K, Mechtler L, West C, Grand W, Shin K, Sibata C, West C, Mechtler L, Grand W, Thomas R, Guerrero D, James N, Ashley S, Gregor A, Brada M, Voges J, Sturm V, Bramer R, Pahlke H, Lehrke R, Treuer H, Banik N, Kim DG, Hövels M, Bernsen HJJA, Rijken PFJW, Van der Sanden BPJ, Hagemeier NEM, Van der Kogel AJ, Koehler PJ, Verbiest H, Jager J, Vecht CJ, Ross GM, McIlwrath A, Brown R, Mottolesb C, Pierre'Kahn A, Croux M, Roche JL, Marchai J, Delhemes P, Tremoulet M, Stilhart B, Chazai J, Caillaud P, Ravon R, Passacha J, Bouffet E, Dirven CMF, Mooy JJA, Molenaar WM, Lewandowicz GM, Grant N, Harkness W, Hayward R, Thomas DGT, Darling JL, Delepine N, Subovici II, Cornille B, Markowska S, Alkallaf JCD, KühI J, Niethammer D, Spaar HJ, Gnekow A, Havers W, Berthold F, Graf N, Lampert F, Maass E, Mertens R, Schöck V, Aguzzi A, Boukhny A, Smirtukov S, Prityko A, Hoiodov B, Geludkova O, Nikanorov A, Levin P, Rothbart D, Balledux J, Criscuolo GR, D'haen B, Van Calenbergh F, Casaer P, Dom R, Menten J, Goffin J, Plets C, Hertel A, Hernaiz P, Seipp C, Siegler K, Baum RP, Maul FD, Schwabe D, Jacobi G, Kornhuber B, Hör G, Menten J, Casaer P, Pilkington GJ, Merzak A, Rooprai HK, Bullock P, van Domburg PHMF, Wesseling P, Thijssen HOM, Wolff JEA, Boos J, Krähling KH, Gressner-Brocks V, Jürgens H, Schlegel J, Scherthan H, Arens N, Stumm G, Kiessling M, Merzak A, Koochekpour S, Pilkington GJ, Reifenberger G. Abstracts. J Neurooncol 1994. [DOI: 10.1007/bf01070874] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|